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Abstract
mRNA localization is an essential process in the spatiotemporal regulation of gene expression. In
this process, the cell restricts and controls different steps of the "mRNA life-cycle" by the dynamic
assembly of ribonucleoprotein particles. These particles are composed of networks of mRNAs
containing cis-acting elements that are recognized by trans-acting RNA-binding proteins. The RNA
binding proteins can thus influence the mRNA fate by acting directly or indirectly on the RNA at
every step of the process.
One of the best described trans-acting factors in mRNA localization is Staufen, a conserved
double-stranded RNA binding protein (dsRBP). Staufen was first described as a determinant for
the localized translation of maternal mRNAs in the Drosophila melanogaster oocyte. In mammals,
two Staufen homologs have been identified Staufen1 and Staufen2. Both proteins regulate the
transport and translational localization of specific mRNAs in different cell types. Additional to its role
in localization, Staufen1 and Staufen2 affect target mRNA stability. Several mRNAs targets have
been reported as specific targets of Staufen, some of the best-characterized are the bicoid mRNA
(bcd) in Drosophila melanogaster and the ADP-ribosylation factor 1 (ARF1) mRNA in humans.
Staufen is a multidomain protein composed of four to five dsRNA binding domains (dsRBD). The
canonical dsRBDs dsRBD3 and dsRBD4 have been shown to bind dsRNA in vitro. dsRBD2 and
dsRBD5 are shorter domains that differ from the canonical dsRBD. Interestingly, dsRBD2 has RNA-
binding activity whereas dsRBD5 is a non-RNA binding domain that mediates protein-protein inter-
actions, and in the case of Staufen1 and Staufen2 is involved in protein dimerization. The fact that
the canonical dsRBDs recognize specifically RNA secondary structures but lack sequence-specific
discrimination opposes with Staufen specificity. Structural data of the Drosophila melanogaster
dsRBD3 in complex with an artificial stem-loop, give some insight into the molecular basis of this
interaction. However, the information is limited to a single dsRBD and a non-physiological relevant
RNA.
In this thesis, I report the solution of the structure of dsRBD3 and dsRBD4 of the hStaufen1 in
complex with a physiological dsRNA sequence encoding the ARF1 Staufen binding site. The
structure shows that the two domains wrap around the RNA duplex, that remains unchanged
upon binding. Several interactions between the dsRBDs and the RNA sugar-phosphate backbone
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were observed. Furthermore, both dsRBDs exhibit direct base interactions in both dsRNA minor
grooves mediated by conserved Staufen residues. Evaluation of the affinity in vitro, by mutating
the residues involved in the interaction suggests a stronger contribution by residues mediating
nonspecific interactions compared to a negligible contribution of residues involved in base-directed
interactions. However, in vivo experiments in Drosophila melanogaster showed that residues
involved in base-directed interactions are significant contributors to accomplish binding accuracy.
The biochemical and structural data presented here, indicate that affinity and specificity of RNA
recognition by Staufen are based on the interplay of its canonical dsRBDs.
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mRNA-Lokalisierung ist ein essenzieller Mechanismus der räumlich und zeitlich regulierten Gen-
expression. Dieser Mechanismus ermöglicht der Zelle die Kontrolle und Überwachung der un-
terschiedlichen Phasen des mRNA-Lebenszyklus durch die dynamische Zusammenstellung von
Ribonucleoprotein-Partikeln. Diese Partikel beinhalten Netzwerke von Komplexen aus mRNA-
Molekülen und mRNA-bindenden Proteine. Die mRNA-Moleküle sind gekennzeichnet durch
cis-wirkende Elemente, welche von trans-agierenden Faktoren, sogenannten mRNA-bindenden
Proteinen, erkannt werden. Die mRNA-bindenden Proteine beeinflussen somit jede Phase des
mRNA-Lebenszyklus, indem sie direkt oder indirekt mit der RNA interagieren.
Eines der am besten charakterisierten trans-agierenden Faktoren bei der mRNA Lokalisierung ist
Staufen, ein konserviertes doppelsträngige-RNA-bindendes Protein (dsRBP). Staufen wurde als
ein wichtiger Faktor bei der lokalen Translation von maternalen mRNAs in der Taufliege Drosophila
melanogaster identifiziert. In Säugetieren, existieren zwei Homologe, Staufen1 und Staufen2.
Beide Homologe werden benötigt, um den Transport und die lokale Translation von spezifischen
Transkripten in verschiedenen Zelltypen zu regulieren. Neben ihrer Rolle in der Lokalisierung
wirken sich Staufen1 und Staufen2 auf die mRNA-Stabilität aus. Mehrere spezifische Transkripte
von Staufen wurden bereits identifiziert. Die am besten charakterisierten Transkripte sind die bicoid
mRNA (bcd) in Drosophila melanogaster und die ADP-Ribosylierungsfaktor 1 mRNA (ARF1) in
Menschen.
Staufen ist ein Multidomänenprotein und besteht aus vier bis fünf doppelsträngige-RNA binden-
den Domänen (dsRBD). Davon gehören dsRBD1, dsRBD3 und dsRBD4 zu den kanonischen
dsRBDs, die dsRNA in vitro binden können, im Unterschied dazu stehen dsRBD2 und dsRBD5,
welche verkürzt sind. Interessanterweise konnte für dsRBD2, im Gegensatz zu dsRBD5, eine RNA-
bindende Aktivität nachgewiesen werden. dsRBD5 beteiligt sich an Protein-Protein-Interaktionen
und im Fall von Staufen1 und Staufen2 an der Dimerisierung der Proteine. Die Tatsache, dass die
kanonischen dsRBD bestimmte Sekundärstrukturen erkennen, aber keine spezifische Sequenzen
diskriminieren können, steht im Kontrast zur nachgewiesenen Spezifität von Staufen. Strukturelle
Informationen aus dem Komplex von Drosophila melanogaster dsRBD3 mit einer künstlichen
RNA-Haarnadelstruktur ermöglichen einen Einblick in die zugrunde liegenden molekularen Mecha-
nismen der Interaktion. Allerdings beschränkt sich diese Information auf eine einzige dsRBD und
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eine unphysiologische RNA.
In der vorliegenden Doktorarbeit, wurde die Struktur des Komplexes aus hStaufen1 dsRBD3 und
dsRBD4 mit der physiologischen dsRNA Sequenz der ARF1 Staufen Bindungstelle bestimmt. In
der Struktur binden die zwei Domäne das RNA-Duplex ein. Durch die Interaktion konnte keine
signifikante Veränderung in der Struktur des RNA-Duplex festgestellt werden. In der Struktur ist
deutlich zu erkennen, dass Interaktionen der dsRBDs mit dem Zucker-Phosphat-Rückgrat der RNA
überwiegen. Zudem weisen beide Domänen, vor allem über konservierte Proteinreste im Staufen,
direkte Interaktionen mit den Basen in beiden kleine Furchen der dsRNA auf. Analysen der Affinität
in vitro haben gezeigt, dass Mutationen der Proteinreste, die an indirekten Interaktionen beteiligt
sind, erhebliche negative Effekte auf die Affinität hatten, während Mutationen der Proteinreste,
die an direkten Interaktionen beteiligt sind, nur marginale Effekte aufwiesen. In vivo Experimente
an Drosophila melanogaster haben jedoch gezeigt, dass die an direkten Interaktionen beteiligte
Proteinreste einen wesentlichen Beitrag leisten, um eine vollkommene Bindung mit der RNA
zu erreichen. Die hier präsentierten biochemischen und strukturellen Daten legen nahe, dass
die Affinität und Spezifität der dsRNA-Erkennung von Staufen auf das Zusammenspiel seiner
kanonischen dsRBDs basieren.
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1 Introduction
1.1 Post-transcriptional gene regulation
The transfer of genetic information via Ribonucleic acids (RNAs) to produce proteins is a conserved
process across species. In eukaryotes, this process increases in complexity by the presence of
new compartments in the cell and the requirement of cell differentiation. These changes may have
led to the adaptation and specialization of regulatory mechanisms (Anantharaman, 2002).
At the post-transcriptional level, these regulatory mechanisms are present at all stages of the
messenger RNA (mRNA) life cycle including transcription, maturation, transport, and degradation
(Wilusz and Wilusz, 2004, Fasken and Corbett, 2005, 2009). This multi-step process starts in the
nucleus when the new mRNA (pre-mRNA) molecule is transcribed by RNA polymerase II (Pol II).
During transcription, the nascent pre-mRNA molecule is modified. These modifications include
5´-end capping, splicing (intron removal), 3´-end cleavage, polyadenylation and other regulatory
modifications such as RNA editing (Colgan and Manley, 1997, Maniatis and Reed, 2002, Proudfoot
et al., 2002, Proudfoot, 2011). The matured and polyadenylated mRNA is then exported to the
cytoplasm (Fasken and Corbett, 2005, Carmody and Wente, 2009, Rodríguez-Navarro and Hurt,
2011). In the cytoplasm, the mRNA is then translated by the ribosome. Before translation, the
mRNA can be localized or stored (Martin and Ephrussi, 2009). Finally, the mRNA is targeted for
degradation (Dreyfuss et al., 2002, Moore, 2005, Braunschweig et al., 2013, Bentley, 2014) (Fig.
1.1).
From birth to decay, the mRNA molecule is bound by a multitude of proteins. Cis-elements on
the mRNAs are recognized by trans-acting factors (mainly mRNA binding proteins) to mediate
the regulatory dynamics. A large variety of mRNA binding proteins (mRBPs) bind mRNA to form
mRNA ribonucleoprotein particle (mRNP). The trans-acting factors contained in this particle can
bind stably or transiently to other protein factors at different steps and so modulate the function in a
combinatory way.
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Figure 1.1. Schematic of post-transcriptional gene regulation PTGR in eukaryotes. In the nucleus,
RBPs already bind the nascent pre-mRNAs (capping) and together with cis-elements facilitate their
maturation and modification (splicing). Other mRBPs escort the mature mRNAs and enable their export
to the cytoplasm. Once there, the mRNA can be translated. After translation is completed, the mRNA is
then marked for degradation.
1.2 RNA binding proteins
In order to understand the mechanisms behind the events that regulate gene expression, it is
necessary to elucidate not only the composition of mRNPs but also the molecular basis of recogni-
tion and interactions of trans-acting factors. Most of these trans-acting factors are mRBPs. The
knowledge of the exact composition of mRNPs at different steps is still limited. However, in recent
years various biochemical, genomics and bioinformatics studies have identified mRNP components
in different cell types (Burd and Dreyfuss, 1994, Johnston et al., 1992, Lunde et al., 2007).
Different classes of mRBPs have been identified, some of them are universaly conserved, others
are only found in eukaryotes or in metazoans (Anantharaman, 2002). mRBPs are often modular
proteins containing two classes of domains : (1) RNA binding domains (RBDs) that can recognize
and bind mRNA; this binding can be sequence-specific and restricted to the recognition of structural
elements within the mRNA. (2) Enzymatic and non-enzymatic domains related to functions other
than mRNA binding (Anantharaman, 2002). Although most of these proteins contain only one RBD,
there are groups that are characterized by the presence of multiple RBD repeats or a combination
of class one and two. The combination of domains achieves an extended level of gene regulation,
by allowing the protein to bind to the target with different affinities and specificity (Lunde et al.,
2007).
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1.3 Structural classification of RNA binding proteins
Structural and biochemical characterization gives insight into the recognition and binding mode of
different mRBPs. This characterization allows the classification of the individual domains present in
mRBPs. These domains have a particular fold and RNA binding activity, that reflects the adaptation
of mRBPs to different biological functions during evolution (Anantharaman, 2002).
Different biochemical and structural methods together with bioinformatic approaches identified
several RBD classes. The most common RNA binding domains are the RNA-Recognition Mo-
tif (RRM), the K-Homology domain (KH), the zinc finger (zf) and the double-stranded RNA Binding
domain (dsRBD) (Fig. 1.2).
Figure 1.2. Architecture and domain composition of representative RNA binding domains of RBPs.
RBPs can have one RBD or multiple copies connected by flexible loops. This modular architecture
contributes to the target recognition. However, the topology differs for each class and allows RBPs to
function in diverse aspects of PTGR.
1.3.1 RRM
The RRM (also known as the RNA-binding domain, RBD) is the most abundant eukaryotic RBD and
the best characterized. RRM containing RBPs are involved in many aspects of RNA regulation and
PTGR (Dreyfuss et al., 2002, Maris et al., 2005, Auweter et al., 2006). The RRM is about 90 amino
acids long and adopts a babbab topology (Fig. 1.3). Two conserved regions characterize the RRM.
Region one is present in b-strand 1 (know as RNP-2) and region two in b-strand 3 (know as RNP-1)
(Adam et al., 1986, Swanson et al., 1987). The domain can bind single-stranded RNA (ssRNA)
and single-stranded DNA (ssDNA) as well as mediate protein-protein interactions (Bandziulis et al.,
1989, Kenan et al., 1991, Birney et al., 1993). Commonly, more than one copy is present in an
RBP, and the interplay between the domains influences the function of the protein. Multiple RRMs
can bind to ssRNA cooperatively, or have different specificities (Lunde et al., 2007, Anantharaman,
2002).
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Conserved aromatic residues present in RNP-1 and RNP-2 are essential for RNA binding and
recognition. Typically, these residues allow the domain to recognize specific sequences and to
make stacking interactions with the RNA bases. Additionally, RNA binding specificity is obtained by
the fourth b-sheet, where at least four nucleotides (nt) of ssRNA can be specifically recognized
through hydrogen bonds and van der Waals interactions (Auweter et al., 2005, Lunde et al., 2007,
Cléry et al., 2008). An example of this mode of recognition is shown by the structure of the Fox1
protein bound to the RNA heptamer UGCAUGU (Fig. 1.3)(Auweter et al., 2005). Three conserved
residues (His120, Phe158, and Phe160) located in RNP-1 and RNP-2 bind specifically to two
nucleotides (U5 and G6) (Fig. 1.3 B upper panel). Additionally, Fox1 RRM exhibits an extended
RNA binding surface, where the loop between b-strand 1 and a-helix 1 recognizes four further
nucleotides (U1, G2, C3, and A4) (Fig. 1.3 B bottom panel) (Auweter et al., 2005). As for the
Fox1 protein, the length of the loops between secondary structure elements within the RRM, and
extension of the N- C- termini can provide an extended binding region in different RRM-containing
proteins. These extensions allow the domain to recognize variable length of ssRNA (up to eight
nucleotides) and to modulate the binding affinity (Maris et al., 2005, Auweter et al., 2005, Lunde
et al., 2007, Cléry et al., 2008, Muto and Yokoyama, 2012).
Figure 1.3. Representative RRM from the human Fox1 protein. (A) Topology of the RRM fold, colored
by element: a-helices are colored in deep-magenta, b-sheets in teal and loops in lemon green. (B)
nuclear magnetic resonance (NMR) structure of the RRM of human Fox1 in complex with a ssRNA
heptamer. The domain shows the typical RRM fold (Protein Data Bank (PDB) : 2ERR) (Auweter et al.,
2005). On the right equivalent view rotated by 90°, the upper panel shows an enlarged view of the
canonical binding mode and the bottom panel shows extensions of the RNA binding mode. The structure
is colored as in A, RNA is colored in gray, residues and bases involved in the interaction are represented
as sticks, bases are colored in light orange. Illustrations of the protein structure used in all figures were
generated with the PyMOL Molecular Graphics System, Version 2.0 (Schrödinger, LLC, 2015)
1.3.2 KH
The KH domain was first described in the human heterogeneous nuclear RNP K Protein (hNRNP K).
This domain can bind to ssRNA and ssDNA and is involved in a variety of cellular functions such as
splicing, transcription, and translation. The minimal KH motif (baab) has a topology that include a
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consensus sequence (I/L/V)IGXXGXX(I/L/V) (GXXG motif) loop between a-helices 1 and 2, and
a variable loop (3 to 60 aa) that connects b-strand 2 with an ab extension module (a´b´) (Fig.
1.4 A) (Grishin, 2001, Valverde et al., 2008). This conserved domain evolved in two folds, type I
(eukaryote-specific) and type II (prokaryote-specific), that differ in the position of the minimal KH
motif (Fig. 1.4 A) (Grishin, 2001, Lunde et al., 2007, Valverde et al., 2008). Type I is characterized
by a baabba topology; the minimal KH motif is located at the N-terminus and followed by the
variable loop with the ba module. This type is usually present as a single domain in RBPs (Grishin,
2001, Valverde et al., 2008). In contrast, type II adopts a abbaab topology where the variable loop
connects an ab module with the minimal KH motif at the C-terminus. This type is predominantly
found as multiple repeats (Grishin, 2001, Valverde et al., 2008).
Figure 1.4. Representative KH domain from the Nova 2 protein. (A) Topology of type I and II KH folds
colored by element: a-helices are colored in deep-magenta, b-sheets are colored in teal, loops are
lemon green, GXXG motif is colored in yellow, and the variable loop is represented as an orange dotted
line. (B) X-ray structure of the KH3 domain of the protein Nova 2 in complex with an RNA stem-loop
(PDB: 1EC6) (Lewis et al., 2000). The panels show an expanded view of the interactions with the
50-UCAC-30 sequence present in the RNA loop. On the right equivalent view rotated by 90°that shows
the binding cleft formed by the minimal KH motif and the variable loop. The structure is colored as in A,
RNA is colored in gray, residues and bases involved in the interaction are represented as sticks, bases
are colored in light orange. Dotted lines indicate hydrogen-bonds, water molecules are represented as
light grey spheres.
The RNA binding surface extends to the C-terminal region of the minimal KH motif. The two
a-helices with the conserved GXXG motif are positioned face to face with the b-strand and the
variable loop (Fig. 1.4 B). The formed cleft allows the recognition of a maximum of four nucleotides
by van der Waals contacts, hydrogen bonds and hydrophobic interactions. This mode of binding
is well illustrated by the structure of the KH3 of the Neuro-oncological ventral antigen 2 (Nova 2)
protein bound to a ssRNA loop ( Fig.1.4) (Lewis et al., 2000). This domain belongs to the KH type I,
and recognizes the 50-UCAC-30 sequence present in the RNA loop. For this, Lys23, in the GXXG
motif, and Arg75, in a´-helix make a water-mediated interaction with U12. Residues in a-helix 1
and b´-strand, as well as residues in the b-strand 2, interact directly with C13 and C15 respectively.
Finally, A14 is in hydrogen-bonding with the backbone of Ile41. Additional electrostatic interactions
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with the RNA backbone stabilize the complex (Lewis et al., 2000). The RNA affinity of a single KH
domain is low (micromolar range), compared to other RBDs. Nevertheless, the presence of multiple
repeats in a protein increases the affinity of binding to the nanomolar range (Beuth et al., 2005,
García-Mayoral et al., 2007).
1.3.3 CCCH, CCHH and CCHC zf
The zf is a conserved domain that can bind RNA as well as DNA (Miller et al., 1985, Clemens et al.,
1993). The domain is about 20 to 30 amino acids long and contains four metal-binding residues;
these can be cysteines and histidines in different combinations. Their number and order determine
the classification of the zf (CCCH, CCHH or CCHC). The four metal-binding residues coordinate a
zinc ion (Zn2+) that forms and stabilizes the structure of the domain (Lu et al., 2003, Hudson et al.,
2004, Lunde et al., 2007).
Figure 1.5. Representative zf from the human TIS11d protein. (A) The CCCH zinc finger motif (three
Cys and one His residues bonded to a Zn2+ ion) colored by element: a-helices are colored in deep-
magenta, and loops in lemon green. zinc ions are represented as grey spheres. (B) NMR structure of
the two zf of TIS11d protein in complex with an AU-rich element (PDB: 1RGO) (Hudson et al., 2004).
The panels show an expanded view of the interactions of the zf 1 (right) and zf 2 (left) with the RNA.
The structure is colored as in A, RNA is colored in gray, residues and bases involved in the interaction
are represented as sticks, bases are colored in light orange. Dotted lines indicate hydrogen-bonds.
In eukaryotes, Zn fingers have been shown to be involved in the regulation of different aspects of
mRNA metabolism. The mode of recognition depends on the Zn fingers type. The CCHH type can
interact with the backbone of double-stranded RNA (dsRNA), and also with bulged bases of the RNA
(Lu et al., 2003). In contrast, the CCCH and CCHC type can bind ssRNA in a sequence-specific
manner, through hydrogen bonds (Hudson et al., 2004). This sequence-specific mode of recognition
is illustrated in the structure of the two zf domains (CCCH-type) of the human TIS11d protein in
complex with an AU-rich element ( 50-UUAUUUAUU-30) in Fig. 1.5. Both Zn fingers recognize the
UAU motif through hydrogen bonds between the protein backbone and the Watson-Crick edges
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of the bases (Fig. 1.5 top and bottom panel). Furthermore, stacking interactions (Fig. 1.5 middle
panels) stabilize the interactions (Hudson et al., 2004). Typically, zf domains are present in multiple
repeats or in combination with others RBD.
1.3.4 dsRBD
The dsRBD was first identified in a sequence-based database screen that showed that a common
65-70 amino acid region was present in proteins that specifically recognize dsRNA, such as the
Xenopus laevis RNA-binding protein A (Xlrbpa), the human TAR-binding protein (TRBP) and the
Drosophila Staufen (DmStau) protein (Johnston et al., 1991). A subsequent search in the protein
database identified further dsRBD-containing proteins with a high sequence similarity to the dsRBD
motif, including Escherichia coli RNase III (March et al., 1985), responsible for dsRNA cleavage,
dsRNA-dependent protein kinase (PKR), which control protein translation (Meurs et al., 1990,
Green and Mathews, 1992) and dsRNA-dependent adenosine deaminase (ADAR), that catalyze
the modification of adenosine to inositol in dsRNA molecules (Kim et al., 1994, O'Connell et al.,
1995) among other proteins (Fig. 1.6).
Figure 1.6. Multiple sequence alignment of dsRBDs in dsRBPs of different species: Drosophila
melanogaster (Dm), Escherichia coli (Ec), Homo sapiens (Hs), Xenopus laevis (Xl). Conserved residues
with structural function are highlighted in blue, residues involved in dsRNA binding are highlighted in
red. Secondary structure elements are represented as cartoon below the alignment. The three major
regions that make contact with dsRNA are indicated.
Binding experiments confirmed that dsRBDs in Xlrbpa and DmStau bind with high affinity to dsRNA
secondary structures but poorly if at all to ssRNA and double-stranded DNA (dsDNA) (Johnston
et al., 1992). The identification and biochemical characterization of these dsRBPs confirmed the
existence of a functional domain capable of interacting specifically with dsRNA (Johnston et al.,
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1992, Green and Mathews, 1992). The list of dsRBPs is still growing today, and the vast variety of
these proteins are active in almost all aspects of mRNA metabolism.
Table 1.1. Representatives members of dsRBPs
dsRBP species function domains
RNAse III Escherichia coli dsRNA-specific
endoribunoclease.
RNase III domain and
dsRBD
Staufen Drosophila melanogaster mRNA localization, dsRBD A and B
translational regulation,
H.sapiens mRNA decay. dsRBD A and B, Tubulin
binding domain (TBD)
TRBP H.sapiens Induce human
immunodeficiency virus
(HIV) expression,
dsRBD A and B
regulation of innate immune
pathways,
RBPA Xenopus laevis associated with ribosomes
and hnRNPs.
PKR H.sapiens transcriptional and
translational regulation,
dsRBD A and Protein
kinase
regulation of innate immune
pathways,
control of cell growth,
differentiation and
apoptosis.
ADAR1 H.sapiens adenosine to inosine RNA
editing
Zalpha, dsRBD, deaminase
ADAR2 dsRBD A, deaminase
NF90 H.sapiens Transcriptional,
post-transcriptional and
translational regulation;
Domain associated with
zinc fingers (DZF) and
dsRBD A
participates in innate
antiviral response.
The dsRNA binding domain consists of 65-70 amino acids and is present in a vast number of
proteins in eukaryotes, prokaryotes, and viruses. The N-terminal part of the dsRBD varies in differ-
ent species while the C-terminal part shows high conservation (Fig. 1.6). Mutation of conserved
residues, present in three regions of the domain (Fig. 1.6), can decrease or abolish dsRNA-binding
activity (Johnston et al., 1992, Bycroft et al., 1995, McMillan et al., 1995, Krovat and Jantsch, 1996,
Ramos et al., 2000). The number of dsRBDs found in dsRBPs varies from one (more common in
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viruses) to multiple copies. A large variety of dsRBPs contain a combination of dsRBDs with other
domains (Table 1.1).
NMR studies of E.coli RNase III and of the third dsRBD of DmStau reveal a abbba topology (Bycroft
et al., 1995, Kharrat et al., 1995) Fig. 1.7 B), in which the two a-helices at the N- and C- termini
fold against the three stranded antiparallel b-sheet (Fig. 1.7) A). Mutagenesis experiments indicate
that conserved basic residues present on the surface of the domain in dsRBD1 of the human PKR
protein (McMillan et al., 1995) and the dsRBD3 of the DmStau protein (Bycroft et al., 1995) interact
with the negatively charged backbone of the RNA. Successive studies in other dsRBPs confirmed
that mutations in this conserved region of the domain mostly abolish or reduce RNA binding (Green
and Mathews, 1992), (Bycroft et al., 1995, Kharrat et al., 1995, Krovat and Jantsch, 1996).
Figure 1.7. Structure, topology and substrate binding by a representative dsRBD domain: the dsRBD3
of DmStaufen. (A) Topology of the dsRBD colored by element: a-helices are colored in deep-magenta,
b-sheets are colored in teal, loops are lemon green. (B) NMR structure of the dsRBD3 of DmStaufen.
The hydrophobic core of the domain contributes to the stability and correct fold of the domain (PDB:
1STU) (Bycroft et al., 1995). C NMR structure of the dsRBD3 of DmStaufen in complex with an artificial
RNA stem-loop (PDB: 1EKZ) (Ramos et al., 2000). Residues along helix a1, the loop between strands b
1 and b 2 (loop 2) and the conserved N-terminal part of helix a2 recognize the ribose 2´OH groups and
the RNA phosphate backbone. The structure is colored as in A. The RNA is colored in grey, residues
involved in RNA binding are shown by stick representation.
In proteins with multiple dsRBDs, primary sequence derivation of some of the dsRBDs was ob-
served by amino acid insertion, deletion or replacement. These domain variations were mostly
unable to bind dsRNA in vitro (Johnston et al., 1992). Therefore, two types of dsRBD were de-
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scribed: type A, the canonical dsRBD that binds to dsRNA in vitro, and type B, that lacks conserved
motifs for dsRNA binding but is important for protein-protein interactions (Krovat and Jantsch, 1996,
Johnston et al., 1991, 1992). In type A dsRBDs, conserved residues extend through the whole
domain sequence, while in type B conservation is restricted to the C-terminal end (Johnston et al.,
1992).
The hydrophobic core of dsRBDs is formed by conserved residues present in the a-helices 1 and
2 and in the b-strands 1 and 2. These are essential for the correct folding of the domain and
stabilization of residues involved in RNA binding (Kharrat et al., 1995, Bycroft et al., 1995, Nanduri
et al., 1998). In these regions, aliphatic residues allow a tight packing of the domain, while aromatic
residues are important for the stabilization of residues implicated in RNA binding (Krovat and
Jantsch, 1996, Bycroft et al., 1995, Ramos et al., 2000).
1.3.4.1 RNA recognition by dsRBDs
NMR and X-ray structures of different dsRBDs in complex with short dsRNAs (10 to 16 base
pairs (bp)) provide insights into the RNA recognition and interaction of dsRBD (Bevilacqua and
Cech, 1996, Ryter, 1998, Masliah et al., 2012). Structural information of these complexes to-
gether with mutagenesis experiments show a preference for the A-conformation of the RNA double
helix. In this conformation, the RNA minor groove is broad and shallow (11Å wide) allowing in-
teraction with the bases (Delarue and Moras, 1989, Steitz, 1990). In contrast, the major groove
is deep and narrow (4Å wide); here the interaction can be only mediated by 2´OH groups and
the phosphodiester backbone. The presence of the 2´OH groups in ribose sugars represents
a potential interaction surface that could discriminate dsRNA from dsDNA (Delarue and Moras,
1989, Steitz, 1990, Green and Mathews, 1992, Bycroft et al., 1995, Ryter, 1998, Ramos et al., 2000).
Usually, the RNA interaction interface includes three regions within the dsRBD: region 1 is present
in the helix a1, region 2 corresponds to the motif GPxHx in loop 2 between strand b1 and b2, and
region 3 corresponds to the motif KKxAK present in the N-terminal part of helix a2. Region 1 and 2
interact with two successive minor grooves and region 3 contacts the major groove (Ryter, 1998)
(Fig. 1.8 and 1.9)
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Figure 1.8. dsRBD2 of the Nuclear factors 90 (NF90) protein bound to a dsRNA molecule (PDB: 5DV7)
(Jayachandran et al., 2015). The RNA A-conformation is recognized by three regions. Region 1, where
helix a1 (deep-magenta) interacts with the minor groove, region 2 includes residues in loop 2 (green)
that "inserts" into the subsequent minor groove and region 3 corresponds to the conserved residues in
the N- terminal part of helix a2 (deep-magenta) that contacts phosphates of the RNA backbone of the
major groove. Cartoon representation, color coding of structural elements is the same as in Fig. 1.3
Recognition by region 1: a helix 1 Region 1 was identified as a common dsRNA binding
surface in different dsRBDs (Ryter, 1998). However, helix a1 is the least conserved region among
dsRBDs of different proteins (Fig. 1.6) (Johnston et al., 1992, Krovat and Jantsch, 1996). This
amphipathic helix interacts with the minor groove of the RNA. For this, the 2´OH of the RNA riboses
are recognized mainly by water-mediated interactions and some direct interactions. The residues
involved in RNA recognition and interaction are not well conserved (Fig. 1.6). However, the position
where these residues are present is similar in different structures and also the nature of the side
chains at this position is relevant for the interaction. So is the case for position 3, 4 and 8 from
the sequence alignment on Fig. 1.6. Hydrophobic residues mainly occupy position 3. Residues
in this position can place helix a1 in the minor groove by van der Waals interactions with the
ribose and help to correctly position the motif KKxAK in helix a2 for dsRNA binding (Masliah et al.,
2012). Position 4 is represented mainly by polar residues predicted to form hydrogen bonds with
the ribose sugars with some exceptions. One of the exceptions is a methionine, which makes a
sequence-specific hydrophobic interaction with an adenine in the structure of human ADAR2 with
an RNA stem-loop of a natural substrate (Stefl et al., 2010) (Fig. 1.9). In mutation experiments,
the replacement of A to G shows a five-fold binding reduction, confirming that this interaction can
differentiate between AU from GC (Stefl et al., 2010). The last residue in position 8 is a conserved
glutamate; this residue is essential for RNA binding and at the same time is part of the consensus
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sequence (Johnston et al., 1992). The carboxylic group of the glutamate mediates the hydrogen
bond interaction.
Figure 1.9. Global and detailed views of the NMR structure of the dsRBD2 of ADAR2 bound to the
glutamate receptor 2 R/G lower stem-loop mRNA (GluR-2 R/G LSL) (PDB: 2L2K) (Stefl et al., 2010). (A)
View of the dsRBD2 bound to the GluR-2 R/G LSL as cartoon representation. Color coding of structural
elements is the same as in Fig. 1.3. The RNA is colored in gray. Residues that mediate recognition are
shown as sticks and are numbered according to the sequence alignment of Fig. 1.6. Hydrogen bonds
are indicated by black dotted lines. (B) Close-up view of the three regions of contact. In region 1, Met4
makes a hydrophobic and specific contact with A18 (light orange). Val3, Asn7, and Glu8 contact the
bases surrounding this adenine and stabilize the interaction of helix a1; in region 3, the recognition of
the major groove is achieved by Asn55 and the conserved Lys56, Lys57 and Lys60. These residues
are hydrogen bonded with the phosphate backbone in both strands. In region 2, the main chain of
Ser31 makes a hydrogen bond with the amino group of the G9 (light orange). This specific interactions
together with other nonspecific interactions stabilize the binding to the minor groove. (Stefl et al., 2010).
Recognition by region 2: loop between b-strand 1 and 2 This region is well conserved and
consists of a six amino acid long loop with the motif GP XHx (Fig. 1.6). In order to recognize the
subsequent minor groove, the conserved His of the motif bridges the two RNA strands by binding to
the 2´OH of the riboses through hydrogen bonds (Masliah et al., 2012). Structural data on different
dsRBD-dsRNA complexes showed that this region can also contribute to substrate selectivity (Ryter,
1998, Stefl et al., 2010, Jayachandran et al., 2015). For this, the carbonyl group of the peptide
backbone of the third residue in the motif (X) recognizes the amino group of a guanine base in the
minor groove (Ryter, 1998, Stefl et al., 2010), (Masliah et al., 2012, Jayachandran et al., 2015).
This recognition has been observed in the structure of dsRBD2 of Xlrbpa bound to a synthetic 10
bp dsRNA, the dsRBD2 of ADAR2 bound to the glutamate receptor 2 R/G and the dsRBD2 of NF90
with a synthetic 18 bp dsRNA (Ryter, 1998, Stefl et al., 2010), (Jayachandran et al., 2015) (Fig. 1.9) .
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Recognition by region 3: N-terminus of helix a 2 In region 3, the consensus KKxAK motif
present in the N-terminal part of helix a2, is essential for RNA binding (Ryter, 1998). This region
recognizes the dsRNA major groove by making contact with the phosphodiester backbone of
both strands. For this, the first and last Lys of the motif contact the phosphodiester backbone
of one strand while the second Lys contacts the phosphodiester backbone of the other strand
(Ryter, 1998). In this way, the domain can scan and recognize the width of the major groove.
These interactions allow the domain to discriminate between A-form dsRNA and B-form dsDNA
(Ryter, 1998, Bevilacqua and Cech, 1996). The required orientation of the Lys for RNA binding is
predetermined by a set of van der Waals interactions and by the position of this residue in helix
a 2. Some variation is present in the last Lys of the motif: in some cases negative residues can
replace this Lys. However, RNA binding is not affected given that in these cases a Lys from helix a
1 compensates the binding (Masliah et al., 2012).
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1.4 Staufen is a conserved dsRNA binding protein
One of the best-characterized dsRBP is Staufen (Stau). Stau was first isolated from Drosophila
melanogaster (Dm) and identified as a multidomain dsRBP (Johnston et al., 1991, 1992). Further
homologous of Stau were identified in Drosophila virilis, Musca domestica, Caenorhabditis elegans,
Mus musculus and Homo sapiens (Marión et al., 1999, Wickham et al., 1999, Micklem, 2000,
Ramos et al., 2000). Sequence alignment analysis showed that the conservation among the
homologs is restricted to the dsRBDs, and the number of dsRBD copies varied from species to
species (Micklem, 2000). Invertebrate Stau contains up to 5 dsRBD copies, while mammalian Stau
has 4 dsRBDs copies (Micklem, 2000).
DmStau contains 5 copies of dsRBD (Fig. 1.10). From which dsRBD1, 3 and 4 are type A dsRBDs
and dsRBD2 and 5 type B. Northwestern assays showed that dsRBD1, 3 and 4 bind to dsRNA
structures in vitro (Johnston et al., 1992). However, dsRBD3 showed stronger dsRNA binding than
dsRBD1 and 4 (Johnston et al., 1992, Ramos et al., 2000, Micklem, 2000). As for dsRBD2 and 5,
both domains do not interact with dsRNA (Micklem, 2000). Structural and mutagenesis studies of
dsRBD3 of Dm Stau bound to an artificial 12 bp stem-loop identified three RNA binding regions in
the dsRBD, namely helix a1, loop 2 and the N-terminus of helix a2 (Ramos et al., 2000). Conserved
residues in these three regions recognize and interact with two consecutive minor grooves (helix
a1 and loop 2) and with the major groove (N-terminus of helix a2) of the A-form dsRNA. These
residues are conserved through all dsRBD3 Stau homologs (Ramos et al., 2000). Some variation
is present in dsRBD1 and 4, where these residues are either conserved or of the same type as
dsRBD3 (Micklem, 2000). dsRBD2 of all Stau homologs are characterized by the insertion of a
proline-rich region in loop 2 (Micklem, 2000). This insertion inhibits the recognition of the dsRNA
major and minor groove by the domain (Micklem, 2000). As for dsRBD5, the residues involved in
RNA binding are not conserved, while residues that maintain the hydrophobic core are conserved
allowing the domain to fold as a classical dsRBD (Micklem, 2000).
In Mammals, two Stau homologs, Stau1 and Stau2, have been described (Fig. 1.10). Both
homologs are present in several splicing isoforms. Stau1 generates three isoforms that differ
at the N-terminus, and are characterized by the absence of the first dsRBD present in the Dm
protein (DesGroseillers and Lemieux, 1996, Marión et al., 1999, Wickham et al., 1999). Up to
8 isoforms have been described for Stau2 (Buchner et al., 1999, Kiebler et al., 1999, Duchaîne
et al., 2002). They differ at the C-terminus and are characterized by the absence of the last dsRBD
present in the DmStau. Stau1 is ubiquitously expressed whereas Stau2 is restricted to the nervous
system (Marión et al., 1999, Wickham et al., 1999, Duchaîne et al., 2002, Monshausen et al., 2008,
Mallardo et al., 2003).
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Although mammalian Stau (maStau) lacks one dsRBD, it has been shown by filter binding assays
that it can bind dsRNAs with high-affinity in vitro (KD of 10nM) (Marión et al., 1999, Wickham et al.,
1999). As in Dm Stau, the mammalian Stau dsRBD3 is the main determinant of RNA binding
whereas dsRBD4 has a weak binding activity (Marión et al., 1999, Wickham et al., 1999, Luo
et al., 2002). In addition, mammalian Stau homologs contain a functional TBD between dsRBD4
and 5, for the interaction with the microtubule network (Wickham et al., 1999). As mentioned
previously, dsRBD2 and 5 do not bind dsRNA, but could be important for protein-protein interactions
(Marión et al., 1999, Kiebler et al., 1999, Wickham et al., 1999, Martel et al., 2010). Recently, it
was reported that mStau2 dsRBDs1 and 2 could also mediate RNA binding. Nonetheless, the
interplay with dsRBD3 and 4 is still necessary to accomplish high-affinity RNA binding (Heber
et al., 2019). Finally, mammalian Stau includes a conserved motif formed by two a helices, the
Staufen-swapping motif (SSM) (Gleghorn et al., 2013). A flexible linker connects the SSM to the
N-terminus of dsRBD5. The SSM interacts with helix a1 of the dsRBD5 of a second Stau protein to
mediate dimerization (Gleghorn et al., 2013, Martel et al., 2010).
Figure 1.10. Domain organization of DmStau and HsStau. dsRBD implicated in dsRNA binding are
colored in blue and turquoise. The TBD and the SSM are only present in mammals. Bottom left, NMR
structure of the dsRBD3 (blue) of Dm Stau bound to an artificial RNA 12 bp stem-loop (gray) (Ramos
et al., 2000); in the middle is the crystal structure of dsRBD4 (turquoise) of Hs Stau2 (He, F) and on
the right is the crystal structure of the dimerization region of the Hs Stau1 protein, SSM and dsRBD5
(Molecule 1 in dark grey and molecule 2 in light grey) (Gleghorn et al., 2013).
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1.4.1 DmStaufen: a central player for transport and localization
Stau was discovered in Dm, as a determinant for the correct anterior-posterior pattern development
of the embryo (Schupbach and Wieschaus, 1986, St. Johnston et al., 1989, Johnston et al., 1991,
Ephrussi et al., 1991, Kim et al., 2005, Kim-Ha et al., 1995, Broadus et al., 1998, Li et al., 1997).
During oogenesis, DmStau is required for the correct transport and localization of oskar mRNA
(osk) at the posterior pole of the oocyte (Ephrussi et al., 1991, Kim et al., 2005, Kim-Ha et al.,
1995, Johnston et al., 1991). At the posterior pole DmStau is involved in the translational activation
of osk (Micklem, 2000). The Osk protein is required for the formation of the pole plasm and the
translational regulation of nanos mRNA, a determinant for abdomen formation (Ephrussi et al.,
1991, Kim et al., 2005, Kim-Ha et al., 1995, Lehmann and Nusslein-Volhard, 1991). The loop
insertion on dsRBD2 and dsRBD5 of DmStau are required for the localization as well as the
translational regulation of osk (Micklem, 2000). The function of this two domains were tested
in Drosophila mutants by monitoring osk localization (Micklem, 2000). The deletion of the loop
insertion (loop 2) in dsRBD2 (Stau¢loop2) shows that the mutated protein is unable to transport and
localize osk at the posterior pole (Micklem, 2000). A second mutant lacking dsRBD5 (Stau¢dsRBD5)
rescues the wild-type localization of osk, and the colocalization with DmStau, but fails to activate
translation of osk mRNA at the posterior of the oocyte (Micklem, 2000). This data suggests that
loop 2 of dsRBD2 is required for microtubule-dependent localization of osk mRNA at the posterior
pole. Once the mRNA has been localized, dsRBD5 is required for the translational activation of osk
mRNA (Micklem, 2000).
At a later stage of development, DmStau is required for the localization of the maternal bcd at the
anterior pole of the oocyte. bcd is required to produce a gradient of bicoid protein, that determines
the pattern of the head and thorax (Driever and Nüsslein-Volhard, 1988a,b). DmStau binds to the
3´untranslated region (UTR) of bcd (stem-loops regions III, IV, and V) and is recruited into particles
that are transported in a microtubule-dependent manner (Johnston et al., 1991, Ferrandon et al.,
1994). Similar to osk, bcd localization is dependent on the loop insertion on dsRBD2 and dsRBD5
but independent of translation (Micklem, 2000).
During Drosophila neurogenesis, DmStau is required for the localization of prospero mRNA (pros).
By the neuroblast asymmetric division, a larger neuroblast and a small ganglion mother cells (GMC)
are generated. DmStau binds to pros to co-localize basally to the GMC. DmStau mediates the
actin-dependent localization of pros by binding to Miranda through dsRBD5 (Fuerstenberg et al.,
1998). Miranda is an adapter protein, that is also required in the asymmetric localization of Pros-
pero (Shen et al., 1997). Miranda was the first described binding partner of DmStau (Shen et al.,
1998, Fuerstenberg et al., 1998). In the GMC, the Prospero protein acts as a determinant for
differentiation and stem cell fate suppression (Broadus et al., 1998, Li et al., 1997).
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Other functions of DmStau arise in the adult fly, where DmStau is required during long-term memory
formation. The exact mechanisms are not clear yet, but experiments with temperature-sensitive
mutants show that at restrictive temperatures (Stau loss-of-function) short-term memory was abol-
ished in adult flies, while long-term learning was maintained (Dubnau et al., 2003).
1.4.2 Transport and localization by maStau (Stau1 and Stau2)
The role of maStau in transport and localization is well elucidated in the central nervous sys-
tem (CNS). In neurons, both Stau1 and Stau2 are present in the somatodendritic domain of
hippocampal neurons in mRNP (Kiebler et al., 1999, Köhrmann et al., 1999, Tang et al., 2001,
Brendel et al., 2004). However, the localization of both Stau orthologues in hippocampal neurons is
not restricted to the cytoplasm: Stau1 was shown to be present in the nucleus where it interacts
with nuclear RNAs (Le et al., 2000) and Stau2 was shown to shuttle between the nucleus and the
cytoplasm (Macchi et al., 2004, Miki and Yoneda, 2004). Stau2 contains a nuclear localization
signal (NLS) that is present in the unstructured region connecting dsRBD3 and 4 (Macchi et al.,
2004, Miki and Yoneda, 2004). In the nucleus, Stau2 binds dsRNA in order to be exported by
exportin-5 (Exp-5) in a RanGTP-dependent manner (Miki and Yoneda, 2004).
Stau1 and Stau2 were found to be distributed in distinct mRNPs, indicating non-redundant functions.
Indeed each of them has different mRNA targets (Duchaîne et al., 2002, Thomas et al., 2005,
Furic et al., 2007). Biochemical and localization studies of Stau2 in hypocampal neurons identified
two different mRNPs (Kiebler et al., 1999, Mallardo et al., 2003). The first class corresponds to
large particles that are associated either with the nuclear membrane or the rough endoplasmatic
reticulum (RER) and are restricted to the soma of hypocampal neurons (Köhrmann et al., 1999,
Mallardo et al., 2003). The second class corresponds to small particles that can be transported via
microtubules and are distributed in the dendrites (Köhrmann et al., 1999, Mallardo et al., 2003).
Different components present in the maStau-containing RNP have been identified: mRNAs, large
protein complexes that bind to cis-acting elements present in the mRNA 3´UTR, translation regula-
tory factors, ribosomes as well as cytoskeleton and motor proteins (Knowles et al., 1996, Brendel
et al., 2004, Kanai et al., 2004, Villace P, 2004, Fritzsche et al., 2013).The presence of ribosomes
and components required for transport is consistent with previous studies that showed that mam-
malian Stau co-localizes with the RER and associates with tubulin in vitro (Marión et al., 1999,
Wickham et al., 1999). The RNA binding activity of dsRBD3 together with the protein-protein
binding activity of dsRBD4-TBD mediate the Stau-RER and -tubulin interaction (Marión et al., 1999,
Wickham et al., 1999, Duchaîne et al., 2002).
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Among the complex set of proteins found in maStau-containing mRNPs, different translational
regulatory proteins have been identified. These include fragile X mental retardation protein (FMRP),
nucleolin, purine-rich element binding protein A (Pur-a), cap binding protein 80 (CBP80), PABPN1,
components of the RNA-induced silencing complex (RISC) and Pum2 (Brendel et al., 2004,
Fritzsche et al., 2013). The mechanism by which Stau1 and 2 interact with these elements
are not clear, but these elements are part of different mRNA regulatory processes in neurons. It is
therefore likely that Stau works as an adapter protein in different regulatory processes.
The presence of nuclear proteins in Stau-containing particles indicates that the mRNP-complexes
are previously assembled in the nucleus and exported to the cytoplasm for transport and local-
ization (Le et al., 2000). These processes correlate with the nucleo-cytoplasmic distribution of
Stau and with its capability of actin- and microtubules-dependent localization (Broadus and Doe,
1997, Micklem, 2000). Likewise, the high enrichment of translational regulators in Stau-containing
mRNPs suggests that Stau might play a role in translational control, as described in Dm for osk
mRNA. Indeed, it was shown in human cells that Stau1 up-regulates the translation of specific
mRNAs that harbor structured elements in their 5´UTRs. For this, Stau1 binds to the structured
5´UTRs and destabilizes the mRNA to facilitate the recruitment of initiation factors and the ribosome
(Dugre-Brisson et al., 2005).
As for Dm, mammalian Stau is also implicated in neurogenesis. During early neuronal development,
neural stem cells also known as radial glial cells (RGCs) divide asymmetrically to form a new
RGC and an intermediate progenitor cell (IPC) (Paridaen and Huttner, 2014). This asymmetric
cell division is mediated by mRNP that contain Stau2 and other dsRBP (translational repressor
Pum2 and RNA helicase DDX1) (Vessey et al., 2012). During this process, Stau2 regulates the
transport and localization of proneurogenic mRNAs such as Prox1, Trim32 and b-actin in the RGC
to asymmetrical segregate into the differentiated cell IPC and suppress the RGC state (Vessey
et al., 2012, Kusek et al., 2012).
In the mature nervous system, Stau1 and Stau2-containing RNP particles play a role in dendritic
spine morphogenesis and synaptic plasticity. Both proteins are implicated in dendritic spine growth
(Vessey et al., 2008). Experiments in rodents showed that knockdown of Stau1 or Stau2 results in
morphologic changes in spines (Vessey et al., 2008, Lebeau et al., 2011). In addition knockdown of
Stau1 lead to a significant reduction of the number of dendrites and a reduction in synapsis devel-
opment (Vessey et al., 2008, Lebeau et al., 2011). Although these morphological alterations were
present, learning or memory activity was not affected (Vessey et al., 2008). However, locomotor
activity was decreased (Vessey et al., 2008).
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As for synaptic plasticity, Stau1 and Stau2 exhibit different functions. Stau1 is required for the late
form of long-term potentiation (L-LTP), where it acts as a regulator for transport and localization of
specific mRNAs (Vessey et al., 2008, Lebeau et al., 2011). These specific mRNAs are essential
for spine maturation and synapse function (Yang et al., 2008, Lebeau et al., 2011). Stau2 is
essential for the derepression of the Microtubule-associated protein 1b mRNA (Map1b) to activate
the metabotropic glutamate receptor (mGluR) long-term depression (LTD) (mGluR-LTD) (Lebeau
et al., 2011). These data reinforce the idea that both proteins exhibit non-redundant functions.
The nucleocytoplasmic localization and the RNA binding activity of maStau play a central role in
RNP formation (Kiebler and Bassell, 2006). Stau mediates RNP formation and organization through
its RNA binding activity, protein-protein interactions as well as dimerization and oligomerization
(Marión et al., 1999, Wickham et al., 1999, Luo et al., 2002, Martel et al., 2010, Gleghorn et al.,
2013). Different regions of the protein are involved in RNP formation like dsRBD3 and 4 (RNA
binding activity) and the SSM together with dsRBD5 (protein dimerization). However, it is still
unclear how maStau recognizes its specific targets and how the oligomerization of the protein
affects the RNA recognition.
Besides its functions in the nervous system, Stau was shown to be required for the assembly
of viral mRNPs (Chatel-Chaix et al., 2004, 2007, de Lucas et al., 2010). Stau also influences
the replication, transport, and translation of viral RNA (vRNA) (Chatel-Chaix et al., 2004, 2007,
de Lucas et al., 2010, Banerjee et al., 2014, Dixit et al., 2016). During HIV-1 replication, Stau1
binds to the Gag precursor pr55 to regulate the production of new viral particles (Chatel-Chaix et al.,
2004). Furthermore, Stau2 increases virus production by interacting with the viral regulatory protein,
Rev (Banerjee et al., 2014). During influenza virus infection, Stau1 was shown to bind to the vRNA
directly and to interact with the nonstructural protein 1 (NS1) protein of the virus (de Lucas et al.,
2010). Stau is also required for the replication of Hepatitis C Virus (HCV) and for the transport of
vRNA to facilitate the translation of viral proteins (Dixit et al., 2016).
1.4.3 mRNA stability: Staufen mediated decay
Stau1 has been implicated in the selective degradation of specific mRNAs in a process termed
Staufen Mediated Decay (SMD) (Kim et al., 2005). The model is that Stau1 binds to the 3´UTR of
specific mRNAs and recruits the ATPase/helicase Upf1, a Nonsense-Mediated mRNA Decay (NMD)
component, to induce mRNA decay in a translation-dependent manner (Kim et al., 2007, Gong et al.,
2008, Gong and Maquat, 2011, Gleghorn et al., 2013, Park et al., 2012) (Fig. 1.11). The targets of
SMD are characterized by the presence of a Staufen Binding Site (SBS), located more than 25
nucleotides downstream of a termination codon in the mRNA 3´UTR. SBS are double-stranded
motifs generated either by intramolecular base pairing or intermolecular base-pairing (Kim et al.,
23
CHAPTER 1. INTRODUCTION
2005, 2007) (Fig. 1.11). Intramolecular base pairing refers to the formation of secondary structures
such as stems and loops within the mRNA 3´UTR. In contrast, intermolecular base-pairing is the
interaction between a mRNA 3´UTR Alu element and a partially complementary long noncoding
RNA (lncRNA) (Kim et al., 2007, Gong and Maquat, 2011).
The first identified physiological target of SMD encodes the human ADP-ribosylation factor 1 ARF1
(Kim et al., 2007). ARF1 is a Ras-related G protein that regulates vesicular transport and signaling
molecules (Kim et al., 2007). The ARF1 SBS is located in the first 300 nt of the mRNA 3´UTR.
Within this region, a conserved 19 bp stem (nucleotides 75-93 and 212-194) is required for the
binding of Stau1. The conservation of this duplex in mammals supports the function of this SBS
(Kim et al., 2007). Other SMD target candidates that were found to be upregulated by Stau1 or
Upf1 depletion are c-JUN, SERPINE1, IL7R and GAP43 (Gong and Maquat, 2011).
In a yeast two-hybrid screen, the region of Stau1 that interacts with Upf1 was mapped within the
dsRBD4 and the TBD (Kim et al., 2005). Although SMD was initially described for Stau1, it was
shown that Stau2 could also bind Upf1 with higher affinity than Stau1 (Park et al., 2012). The
binding region of Stau2 to Upf1 differed from the one in Stau1. For Stau2, dsRBD2 and dsRBD3
were mapped in pull-down experiments (Miki et al., 2011). Both protein Stau1 and Stau2 were
shown to interact directly and efficiently with the CH domain of Upf1 in an RNA-independent manner
to trigger mRNA decay (Park et al., 2012). However, these results are controversial since other
studies in HEK293F cells, neuroblastoma cells, myoblast, and primary cortical neurons showed
that Stau1 and Stau2 promote stabilization of its mRNA targets rather that their degradation (Miki
et al., 2011, Ravel-Chapuis et al., 2012, Heraud-Farlow et al., 2013, Sugimoto et al., 2015, Parks
et al., 2017).
The physiological function of SMD is based on cell differentiation. This function was tested in
myogenesis by the differentiation of C2C12 Myoblasts (MBs) to Myotubes (MTs). Therefore,
Stau1 was shown to down-regulate the SMD target PAX3 mRNA that encodes a transcription
factor responsible for the inhibition of MBs differentiation (Gong et al., 2008). Similarly, SMD
regulates adipogenesis. During adipogenesis, Stau1 down-regulates the Krüppel-like factor 2
(KLF2) mRNA, which encodes the antiadipogenic factor KLF2 that inhibits the differentiation
process of preadipocytes into adipocytes (Cho et al., 2012). Cho et al. (2012) additionally found that
the proline-rich nuclear receptor coregulatory protein 2 (PNCR2) is involved in SMD. The authors
then proposed the following SMD model, to induce SMD, Stau1 recruits Upf1. Once Upf1 is bound,
it gets phosphorylated by the SMG1 protein and finally binds to PNCR2. Upf1 binds Stau1 and
PNCR2 with its N-terminal region and with the C-terminal region respectively. The phosphorylated
Upf1 acts as an adaptor protein between Stau1 and PNCR2. Finally, the bound PNCR2 induces
decapping activity and 5´to 3´exonucleolytic activity (Cho et al., 2012).
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Figure 1.11. The Staufen mediated decay (SMD) The SMD is a translational dependent mRNA decay
pathway. SMD activation is achieved by the binding of Stau1 or Stau2 (deep blue) to an SBS (25
nucleotides downstream of a termination codon) present in the 3´UTR of a specific mRNA. Stau1 then
recruits Upf1. Upf1 is phosphorylated by SMG1 to activate the exonucleolytic RNA degradation pathway.
1.5 General properties of Staufen associated RNA targets
The function of Stau in PTGR has been described in different organisms and cell lines. During this
process, several mRNAs have been identified to associate with Stau proteins (Johnston et al., 1992,
Ferrandon et al., 1994, Mallardo et al., 2003, Kim et al., 2005, Furic et al., 2007, Kim et al., 2007,
LeGendre et al., 2012, Heraud-Farlow et al., 2013, Laver et al., 2013, Ricci et al., 2013, de Lucas
et al., 2014, Sugimoto et al., 2015). The identification of these mRNAs had been crucial in order to
understand better the regulation mediated by Stau in different cell types and also helped to elucidate
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novel Stau functions (Ferrandon et al., 1994, Mallardo et al., 2003, Kim et al., 2005, Furic et al.,
2007, Kim et al., 2007, LeGendre et al., 2012, Heraud-Farlow et al., 2013, Laver et al., 2013, Ricci
et al., 2013, de Lucas et al., 2014). Despite the identification of several mRNA targets in different
organisms and cell lines, there are only a few well-characterized physiological targets: the three
stem-loop regions III, IV, and V in the bcd 3´UTR mRNA in Dm and the 19 bp stem in the 3´UTR
of the ARF1mRNA in humans (Johnston et al., 1992, Ferrandon et al., 1994, Kim et al., 2005, 2007).
In recent years, different studies have contributed to determine the sequence-binding preferences
of Stau and to identify new sets of targets for Stau in different species and with different conditions.
For this, different approaches have been implemented such as RNA coimmunoprecipitations (RIPs)
followed by microarray analysis (RIP-Chip) or RIP in tandem with deep sequencing (RIPiT) (Ricci
et al., 2013, Laver et al., 2013). Also, the novel technique RNA hybrid and individual-nucleotide
resolution ultraviolet cross-linking and immunoprecipitation (hiCLIP) (Sugimoto et al., 2015) for the
identification of RNA structural preferences of Stau. The results of these studies show good corre-
lation with the already identifies sequences but also high variation, due to the different expression
levels of Stau as well as different techniques and variation in the experimental conditions.
One of the first transcriptome-wide studies in DmStau in vivo identified three types of Staufen
recognized structures (SRS) common in DmStau targets. All three stems were formed in cis and
had a length between 19 and 12 with few mismatched bases, no unpaired bases or a small number
of unpaired bases and short internal loops (Laver et al., 2013). Additionally, the authors used the
available RIP microarray data from native mammalian Stau1 and Stau2 associated mRNAs to
identify similar SRS (Furic et al., 2007). However, similar structural motifs could not be identified
apart from the already described ARF1 mRNA 19 bp stem (Laver et al., 2013).
Studies in human tissue-cultured cells identified two Stau1 common structure classes present in
SBS; one class are stable secondary structures, such as inverted Alu sequences (Alu targets) or
structures with high secondary structure formation propensity (non-Alu targets) (Ricci et al., 2013).
These elements are found in extended 3´UTRs and can be present in the same transcript to induce
simultaneous binding of multiple Stau1 molecules. The second class structure is more labile and
present in GC-rich coding sequences (CDS), in this region Stau1 can transiently interact with the
active ribosome (Ricci et al., 2013).
Recently, Sugimoto et al. (2015) conduced hiCLIP from cytoplasmic extracts of 293 cells in order
to identify RNA duplexes bound by Stau1. The Stau1-hiCLIP analysis identified RNA duplexes
from which half corresponded to mRNAs while a significant portion corresponded to ribosomal
RNAs (rRNAs), in agreement with previous studies that indicated an interaction of Stau1 with
translating ribosomes(Luo et al., 2002, Ricci et al., 2013). The identification of the SBS ARF1
26
CHAPTER 1. INTRODUCTION
mRNA 19 bp stem accomplished part of the hiCLIP data validation. Furthermore, the authors
found other duplex regions within the ARF1 3´UTR. Interestingly, no significant enrichment of Alu
elements was found. Sugimoto et al. (2015) concluded that this is an indication of predominant
Stau-Alus interactions in the nucleus.
Different regions in the same RNA species were mapped to contain duplexes that bind to Stau1,
in agreement with the preference of Stau1 for intramolecular interactions (Sugimoto et al., 2015).
Nonetheless, the hiCLIP analysis identified some negligible intermolecular interactions with long
non-coding RNAs. hiCLIP duplexes were found primarily in the 3‘UTR region, follow of CDS region
and a small portion in the 5´UTR region. The majority of the Stau1-bound duplexes identified
by hiCLIP showed an average length between 5 to 14 nt, remarkably each strand incorporated
stretches only of purines or pyrimidines. The duplex length was also decisive for the base content,
GC pairs were more common in short duplexes whereas in long duplexes the common was AU
pairs (Sugimoto et al., 2015).
Interestingly, the presence of Stau1-bound duplexes in a specific region affects the translational
state of a transcript (Sugimoto et al., 2015). By ribosome profiling it was demonstrated that depletion
of Stau1 increased the abundance of transcripts harboring duplexes at the 3´UTR region without
affecting translational efficiency. In contrast, the abundance of transcripts with duplexes at the CDS
region remained constant meanwhile translational efficiency increased (Sugimoto et al., 2015).
Revealing the structural and sequence-binding preferences of Stau in different species and cell
lines had been crucial to understand better the mechanism used by Stau in post-transcriptional
regulation. However, the molecular mechanisms used by Stau to recognize structures of varying
lengths and how Stau proteins achieve specific mRNA target recognition remain unclear.
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2 Aim of this thesis
The Staufen protein was one of the first dsRBP identified. Since then, different studies have
elucidated the vital role of the protein in various aspects of post-transcriptional gene regulation
in different species. The functions of Staufen range from transport, localization to degradation of
specific mRNAs. Staufen has a flexible multi-domain architecture that allows not only the binding
of mRNA but also the interaction with other trans-acting factors. Until today biochemical and
biophysical approaches have been used to identify physiological targets of the protein and to give
some insights into the molecular determinants of the interactions with dsRNA. Although some
physiological targets could be determined, the structural information still limited to only dsRBD3 in
complex with an artificial RNA stem-loop. Therefore the aim of my thesis is to gain more structural
information over human Staufen1 (hStau1) and by complexing the protein with the physiological
target ARF1 SBS try to extend the knowledge of the molecular mechanisms used by the protein to
bind and recognize the targeted mRNA. To achieve this aim, I followed the next strategies:
1. Improve the purification protocol of the recombinantly produced hStau1 Full-Length (FL)
protein and truncated hStau1 constructs, to avoid protein aggregation and degradation and to
obtain a high protein yield for crystallization experiments.
2. Reconstitution and production of stable complexes of hStau1 FL and truncated hStau1
constructs with the physiological target ARF1 SBS.
3. Biochemical characterization of the human Staufen1 protein, truncated hStau1 constructs as
well as the complexes with the ARF1 SBS.
4. Crystallization and structural characterization of the complexes that could be reconstituted.
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3 Results
3.1 hStau1 FL solubility and stability in vitro are influenced by ionic
strength conditions
3.1.1 Purification of hStau1 FL protein
To understand the mechanism of hStau1 FL regulation and to characterize the mechanisms of
substrate recognition structurally, it is necessary to produce a considerable amount of pure protein.
For this, different fusion tags and conditions were used in test expression experiments. Although
hStau1 FL could be well expressed with all tags tested, the His6-tagged protein was the only one
that could be successfully purified.
Due to precipitation and degradation, I developed an ad hoc purification strategy to produce hStau1
FL in high amount and with high final purity. The protocol includes an extensive wash with high
salt buffer and ion exchange chromatography (IEX) to remove further nucleic acids contamination.
Nucleic acid contaminants contributed to aggregation and precipitation of hStau1 FL and could
bias downstream experiments. The ionic strength of the buffer affected the stability of hStau1 FL
significantly in the purification process. During dialysis, the protein tended to precipitate when the
salt concentration of the buffer was lower than 300mM (Millimolar) Salt. As a final optimization step,
hStau1 FL was subjected to size exclusion chromatography (SEC). With this protocol, the protein
could be successfully expressed, and produced in a concentration of 10mg of pure protein per liter
of cell culture.
The SEC profile of hStau1 FL showed a monodisperse peak, which eluted as a monomer (Fig. 3.1).
The purified protein was sent for crystallization trials to the crystallization facility in the Max Planck
Institute (MPI) in Martinsried. However, the inherent flexibility of the multidomain nature of hStau1
FL and the weak stability might have hindered crystallization. The recombinantly purified hStau1
FL was used for complex formation experiments and further biochemical analysis.
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Figure 3.1. Representative final purification step and purity of hStau1 FL. (A) Size exclusion chromatog-
raphy (SEC) profile of the hStau1 FL using a Superdex-200 16/60 GL column. Retention volume: 65
ml. (B) Coomassie stained Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel
shows the fractions corresponding to the elution peak. Line I: Sample before the SEC run. The size of
the Molecular Weight (MW) marker is in kDa.
3.1.2 Purification of hStau1 truncations
Different hStau1 deletions mutants were designed, to improve the stability of the protein and to re-
duce flexibility for structural characterization. These constructs were designed based on secondary
structure predictions and conservation.
Figure 3.2. Schematic representation of the hStau1 FLand other truncations generated and analyzed in
this thesis. Domains are shown as solid shapes and unstructured regions as lines.
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The first construct lacks the N unstructured region and contains all dsRBD present in the FL protein
(Fig. 3.2 hStau1dsRBD2-5). A second construct was designed based on the short isoform (Uniprot
identifier: O95793-2) described for the hStau1 protein. This construct lacks the first 81 amino
acids (hStau1DN). These two protein fragments were not only poorly expressed but also degra-
dation issues at the second IEX step limited the purification and further biochemical characterization.
A set of truncations were also designed to analyze the oligomerization of the protein and to un-
derstand the requirements for mRNA-binding activity. Since SSM and dsRBD5 are the primary
determinants involved in hStau1 dimerization (Martel et al., 2010, Gleghorn et al., 2013). A trunca-
tion that lacks these regions hStau1dsRBD2-4 is predicted to be monomeric (Fig. 3.2). A truncation
that consists of dsRBD2, 3 and 4 (hStau1DNDC Fig. 3.2), was also designed with the purpose to
remove the unstructured regions that may interfere with crystallization attempts.
Although the role of dsRBD2 in dimerization is not well understood, it has been shown that dsRBD2
alone can interact with the hStau1 FL (Martel et al., 2010). The proline-rich loop insertion present
in dsRBD2 may affect mRNA binding activity, as in the case of DmStaufen protein (Micklem, 2000).
The N terminus of hStau1 together with the dsRBD2 were removed to analyze the effect of the
dsRBD2 in oligomerization and mRNA binding (hStau1dsRBD3-5 Fig. 3.2). Finally, a construct that
included the dsRNA binding determinants dsRBD3 and 4 was obtained (hStau1dsRBD3-4 Fig. 3.2).
All fragments were successfully expressed and purified with similar conditions as the Full-Length
protein with small variations. The deletions mutants constructs were stable during the whole purifi-
cation. The ionic strength did not affect the stability of the majority of mutants. Minimal degradation
issues were primarily observed in the mutants that contained the C-terminal region (SSM and
dsRBD5).
The yield of the purified mutants ranges from 20-30mg of pure protein per liter of cell culture. After
SEC, all recombinantly purified proteins showed a high homogeneity. The elutions profiles showed
mostly a monodisperse peak (Fig. 3.3). However, in some cases, earlier eluting peaks probably
corresponding to aggregation or nucleic acid contaminants were present in the sample. These
impurities could be easily separated from the target protein. All recombinantly purified proteins
were used for crystallization experiments, biochemical analysis, and interaction studies.
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Figure 3.3b. Representative SEC results for the hStau1 truncations. (A, C, E, G) SEC elution profiles
of the hStau1 mutants in physiological conditions. (B, D, F, H) Coomassie stained SDS-PAGE of the
peak fractions (peak I) of the SEC experiments. Line I: Sample before SEC run. MW marker is in kDa.
3.2 hStau1 dimerization is concentration dependent in vitro
3.2.1 SEC-MALLS analysis of hStau1 FL
hStau1 was shown to dimerize via its SSM and dsRBD5 domain (Martel et al., 2010, Gleghorn
et al., 2013). Both homophilic interactions between the SSM-dsRBD5 of two molecules but also an
interaction of the dsRBD2 with this region through heterophilic interactions have been suggested
(Martel et al., 2010, Gleghorn et al., 2013). This dimerization was not consistent with the initial SEC
analysis of hStau1 that exhibited an elution profile compatible with a monomeric state. However,
further SEC analysis showed altered elution profiles when conditions such as protein concentration
or ionic strength varied.
In SEC experiments, when the concentration of the sample exceeded 10 mg/ml, two peaks were
present in the chromatogram. Also, this was the case when the salt concentration of the buffer was
higher than 150 mM. By analyzing the SEC fractions of the two elution peaks in a SDS-PAGE, two
bands were present in the first elution peak (black arrow Fig. 3.5 D). The lower band had a MW
that corresponded to the protein monomer (MW: 63 kDa), the second band had a MW between
120 and 150 kDa. The upper band was analyzed by Mass Spectrometry (TOPLAB GmbH). The
Mass spectrometry results identified 75% of the human hStau1 protein indicating that the second
peak corresponded to a multimer fraction of the protein (Fig. 3.4).
Figure 3.4. Amino acid sequence of hStau1 FL. The Mass spectometry analysis identified 75% of the
human hStau1 FL. Identified peptides are highlighted in red.
This protein-concentration dependent multimerization effect was also observed in the hStau1dsRBD3-5
mutants that contained the dimerization region. For the hStau1dsRBD3-5, the SEC profile showed a
broad shoulder at a high molecular weight. Similar to the hStau1 FL, the fractions corresponding to
the peak shoulder had two bands. This effect was increased by variation in protein concentration
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and the ionic strength. However, SEC data is based on the shape of the molecule and is strongly
affected by external experimental conditions (Lathe and Ruthven, 1956, Burgess, 2018). Because
of this, SEC coupled with Multi-Angle Laser Light Scattering (SEC-MALLS) was used, to accurately
characterize the oligomerization state of the Full-Length protein and the mutants.
Figure 3.5. Representative SEC analysis of hStau1 FL and hStau1dsRBD3-5 in high ionic strength. (A, C)
SEC profile of the hStau1 FL and hStau1dsRBD3-5 in high ionic strength (300mM NaCl buffer) Retention
volume peak 1: 58 ml and peak 2: 65 ml . (B, D) Coomassie stained SDS-PAGE of the fractions
corresponding to the elution peak. Two peaks are present, the first peak is characterized by a second
band at 120 kDa for the hStau1 FL and hStau1dsRBD3-5 90 kDa (black arrows). Line I: Sample before
SEC run. The size of the MW is in kDa.
Dr.Claire Basquin conducted SEC-MALLS analysis at the MPI in Martinsried. The resulting ex-
perimental absolute molecular mass corresponded to a hStau1 FL monomer and a dimer with
a MW of 68 ± 6 kDa (theoretical MW 63 kDa) and of 162 ± 10 kDa (theoretical MW 120 kDa),
respectively (Fig. 3.6 A). In a second attempt, I performed SEC-MALLS experiments in the Dept.
of protein evolution in the MPI in Tübingen. For this, different protein concentrations were tested.
By increasing the concentration of the sample, the equilibrium shifted to the dimer population as
indicated by the SEC experiments (Fig. 3.6 B).
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Figure 3.6. Representative SEC-MALLS results of hStau1 FL in two different set ups. (A) SEC-profile
of hStau1 FL, the experimental calculated molecular mass of the eluted hStau1 FL is indicated in
blue. (B) Overlay of light scattering data with measured molecular mass of hStau1 FL in three different
concentrations: 4 mg/ml (red), 8 mg/ml (blue) and 15 mg/ml (green). Shifting of the elution peak at
increasing concentrations of hStau1 FL suggest a concentration-dependent multimerization of the
protein. (C) SEC-profile of the hStau1dsRBD3-5 protein, the calculated molecular mass of the eluted
hStau1dsRBD3-5 is indicated in blue. Right box: theoretical MW in black and calculated molecular mass
in blue.
As the hStau1 FL, the SEC profile of the hStau1dsRBD3-5 mutant showed two peaks. The SEC-
MALLS elution profile showed a more clear separation of the two populations. The first peak was
higher as it had on a regular SEC; the calculated molar masses of the two population were 78
± 6 kDa for the first peak and 45 ± 3 kDa for the second peak, which corresponded to the mass
of monomeric and dimeric hStau1dsRBD3-5 (Fig. 3.6 C). In contrast, the SEC-MALLS profile of
hStau1dsRBD2-4 and hStau1dsRBD3-4 exhibited a single symmetric peak as in SEC. The experimental
molecular mass of 39 kDa (theoretical mass 39.6 kDa) and 21 ± 1 (theoretical mass 20.2 kDa)
for hStau1dsRBD2-4 and the hStau1dsRBD3-4, respectively, support the monomeric state of both
constructs in solution (Fig. 3.7 A-B). Altogether, these results support the role of the C-terminal
region of hStau1, consisting of SSM and dsRBD5, as the main determinant of hStau1 dimerization.
Moreover, this data shows the structural heterogeneity of the protein in solution and is consistent
with previous studies in which hStau1 can form dimeric or multimeric states in live cells (Martel
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et al., 2010).
Figure 3.7. Representative SEC-MALLS results of the hStau1 mutants. The experimental calculated
molecular mass is indicated in blue. (A) SEC-profile of the hStau1dsRBD2-4 protein, the calculated
molecular mass of the eluted hStau1dsRBD2-4 is indicated in blue. (B) SEC-profile of the hStau1dsRBD3-4
protein, the calculated molecular mass of the eluted hStau1dsRBD3-4 is indicated in blue. Right box:
theoretical MW in black and calculated molecular mass in blue.
3.3 hStau1 FL binds the ARF1 SBS with high affinity in vitro
3.3.1 Reconstitution of the hStau1 FL - ARF1 SBS complex
Studies have identified the different mRNA features that are likely to be bound by the protein
(Johnston et al., 1992, Ferrandon et al., 1994, Kim et al., 2005, 2007, Laver et al., 2013, Ricci et al.,
2013, Sugimoto et al., 2015). However, few candidates have been determined to bind specifically
to the Staufen protein (Johnston et al., 1992, Ferrandon et al., 1994, Kim et al., 2005, 2007). At
present, the best-described mRNA targets are the stem-loop regions III, IV, and V in the 3´UTR of
the bcd mRNA for the Dm protein (Ferrandon et al., 1994) and the 19 bp stem in the 3´UTR of the
ARF1 mRNA for hStau1 (Kim et al., 2005, 2007).
Secondary structure prediction of the entire 3´UTR of the ARF1 mRNA shows that the region
mapped to bind hStau1 specifically, corresponds to a stem that forms between nucleotides 75-93
and 194-212 (Kim et al., 2005, 2007). Some relevant characteristics of the ARF1 SBS are the
presence of two wobble pairs and the high content of G-C pairs (G-C content: 53%, A-U content:
37% and the wobble G-U 2 10%). To test the mRNA binding capability of hStau1 FL in vitro I used
the ARF1 SBS. The two RNA strands were synthesised (Integrated DNA Technologies, Inc. (IDT)),
resuspended in water and subsequently annealed. SEC experiments were performed to verify
the homogeneity of the annealed ARF1 SBS. The elution profile exhibited a monodisperse peak,
analysis of the peak fractions showed the presence of a single band with no degradation products
(Data not shown). Therefore, I could confirm the homogeneity of the annealed ARF1 SBS.
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The hStau1 FL - ARF1 SBS complex was reconstituted in high ionic strength conditions, because
of high precipitation, and subjected to SEC. The hStau1 FL- ARF1 SBS complex eluted as a
monodisperse peak. The peak shifted to higher molecular weight as compared with the elution
profile of hStau1 unbound, and the 260/280 ratio was increased. The SEC profile was an indication
of complex formation. SDS-PAGE analysis of the peak fractions showed a single band with some
degradation products (Fig. 3.8). It was not possible to analyze the dimerization behavior of hStau1
FL on RNA-binding activity with low ionic strength conditions. These results indicated that hStau1
FL stably interacts with the ARF1 SBS in vitro even in high salt condition. The resulting complex
was set up for crystallization, but no hits could be observed.
Figure 3.8. Representative SEC result of the complex of hStau1 FL with the ARF1 SBS. (A) The
chromatogram shows the elution profile of the complex. Retention volume of hStau1 FL apo (black) and
the complex with the ARF1 SBS (blue) are indicated in the table. The complex elutes as a single peak,
the earlier elution volume together with, the higher 260nm absorbance confirms the presence of hStau1-
ARF1 SBS complex. The second peak corresponds to the RNA excess. (B) The Coomassie-stained
SDS-PAGE shows the fractions that correspond to peak I and the second peak. Line I: Complex sample
before SEC run. The size of the MW is in kDa.
3.3.2 Electrophoretic mobility shift assays of hStau1 FL with 5´FAM ARF1 SBS20bp
Electrophoretic mobility shift assays (EMSA) experiments were performed to verify the reconstitution
of the complex and to determine the binding stoichiometry of the complex. For this, ARF1 SBS
labelled with a 5’-6-FAM fluorescein was used. One nucleotide had to be added to the sequence
because of the fluorescence quenching by the adjacent guanosine of the ARF1 SBS sequence
(referred to as ARF1 SBS20bp ). Different buffer systems were tested. The best running conditions
were up to pH 9.8-10 because of the high pI of the protein (pI: 9.46).
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The recombinantly purified hStau1 FL was able to shift the labeled ARF1 SBS20bp . One single
band was present in the non-denaturing gel (Fig. 3.9 A). This band could correspond to one
molecule hStau1 and one molecule ARF1 SBS20bp . Increasing the concentration of the protein did
not affect band shifting of the complex. This result confirmed the hStau1 FL - ARF1 SBS complex
formation and was consistent with the SEC experiments. The stoichiometry of the hStau1 FL -
ARF1 SBS complex was analyzed by SEC-MALLS analysis. However, SEC-MALLS experiments
failed because of the instability of the complex.
3.3.3 Fluorescence anisotropy of hStau1 FL and 5´FAM ARF1 SBS20bp
To assess the binding affinity of hStau1 FL to the ARF1 SBS20bp Dr. Daniela Lazzaretti conduced
Fluorescence anisotropy (FA) measurements. For this, a range of concentrations of the recombi-
nantly purified hStau1 FL was titrated against a constant concentration of labeled ARF1 SBS20bp .
The binding of the protein changed the fluorescence anisotropy of the label ARF1 SBS20bp , and
these changes were measured. By fitting the data, it was possible to calculate the dissociation
constant (KD). hStau1 FL bound the ARF1 SBS20bp with a KD of 6 ± 1 nM (Fig. 3.9 B). Different
RNAs substrates were tested to analyze the importance for binding of secondary structures in the
RNA-binding activity of hStau1 FL.
Although hStau1 does not bind ssRNA in vivo, FA experiments showed, that hStau1 FL could bind
single-stranded species though with weak affinity compared with dsRNA (KD >100nM). The UG10
oligonucleotide (KD 36 ± 10 nM) bound hStau1 with high affinity due to the formation of secondary
structures like G-tetrad and quadruplex (Burge et al., 2006) and stabilized by the presence of
monovalent cations.
The presence of ssRNA elements or wobble base pairs in the ARF1 SBS did not affect the affinity
(ARF1 SBS20bp KD perfectly complementary (pc) 6 ± 2 nM, ARF1 SBS20bp+hairpin KD 7 ± 0 nM).
Shortening the length of the ARF1 SBS stem reduced the affinity slightly (14 bp ARF1 mRNA KD
7 ± 2 nM). Other mRNA substrates were used, to test the mRNA binding activity of hStau1 FL.
For this, we chose already characterized targets of the DmStaufen protein. The 12 bp artificial
stem-loop described to optimally bind to the dsRBD3 of the DmStau (referred as GC-rich hairpin in
Fig. 3.9 B) (Ramos et al., 2000) showed a similar affinity to hStau1 FL as the ARF1 SBS20bp (KD
of 6 ± 1 nM ). Next, we tested the stem-loop III and Vb of the bcd 3´UTR, these two regions were
identified as the binding region of DmStaufen. Both stems have complex secondary structures, and
also a high GC content. hStau1 FL showed a higher affinity for the stem-loop III (bcd III KD of 9 ± 2
nM) in comparison with the stem loop Vb (bcd Vb KD of 12 ± 3 nM). A possible explanation could
be the higher GC content in the stem-loop III in comparison with stem Vb.
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Figure 3.9. RNA-binding assays with hStau1 FL and the ARF1 SBS20bp . (A) EMSA analysis of the
hStau1 FL interaction with the fluorescent labeled ARF1 SBS20bp . (B) The bar graph comparing the
calculated binding affinity of the hStau1 FL for single (ARF1 SBS 20nt sense strand) or double-stranded
RNA. The calculated KD and their corresponding error (error bars) are the mean and the standard
deviations (SD) of a minimum of three experiments. (Mean KD and SD in nM).
All substrates tested so far contained a high number of GC pairs (> 7GC). The RNA-binding
affinity of hStau1 FL was further characterized by using the K10 Transport and Localization Se-
quence (TLS) RNA that included secondary structures as well as lower GC content in the sequence.
The K10 TLS is a Dm mRNA required for the transport and localization of K10 transcripts within
the oocyte (Serano and Cohen, 1995). The K10 TLS is a stem-loop composed of an 8nt loop
and a 17 bp stem in which two nucleotide bulges are present; the AU content predominates
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against the GC content (2 GC pairs) (Serano and Cohen, 1995). hStau1 FL bound the K10 TLS
with a KD of 9 ± 2 nM. Even though K10 TLS is not a physiological target of hStau1 FL, the
relatively high affinity of hStau1 FL for K10 TLS suggested that secondary structures within the
mRNA play a considerable role for the hStau1 mRNA-binding activity. Finally, two GC pairs were
added at the end of the K10 TLS stem to determine the influence of GC pairs in RNA-binding
affinity. As a result, the affinity improved remarkably with the KD increasing by three-fold (Fig. 3.9 B).
Altogether, the SEC experiments with the biochemical characterization indicated that hStau1 binds
the ARF1 SBS with high affinity in vitro, and supported the idea that the GC content is a primary
determinant for the binding rather than secondary structures elements in the mRNA substrate.
3.4 hStau1 RNA-binding activity induces dimerization independent
of dsRBD2 and the dimerization region
The hStau1 truncations had been used in the previous section to analyze and characterize the
biochemical and structural properties of the RNA-binding activity of the hStau1 protein.
3.4.1 Reconstitution of the hStau1dsRBD2-4- ARF1 SBS complex
The hStau1dsRBD2-4 was used for complex formation with the ARF1 SBS. For this, hStau1dsRBD2-4
was mixed with a 1:1.2 ARF1 SBS excess. After addition of the ARF1 SBS, hStau1dsRBD2-4 tended
to precipitate. The precipitation could be in part resolved by adding 300mM salt. Still, the majority
of the complex precipitated. The resulting complex was then injected in a SEC column.
hStau1dsRBD2-4 could bind the ARF1 SBS in SEC experiments. The elution profile showed a
significant increased 260/280 ratio at the main peak that shifted to high molecular weight (Fig.
3.10). However, the main peak had a shoulder on the right side, the small peak at the end of the
chromatogram represented the excess of mRNA. By analyzing the peak fractions on a SDS-PAGE,
no contamination or degradation products were present, and the hStau1dsRBD2-4 band extended
through the whole main peak. This result suggested that hStau1dsRBD2-4 could bind the ARF1
SBS in vitro, despite the lack of the dimerization region. Nevertheless, the formed hStau1dsRBD2-4 -
ARF1 SBS complex was not homogeneous.
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Figure 3.10. Representative SEC result for the hStau1dsRBD2-4 - ARF1 SBS complex. (A) SEC elution
profile of the hStau1dsRBD2-4 - ARF1 SBS complex. Retention volume of the hStau1dsRBD2-4 apo (black)
and the complex with the ARF1 SBS (blue) are indicated in the table (B) The Coomassie-stained
SDS-PAGE shows the peak fractions (peak I) of the SEC. Line I: Complex sample before SEC run. The
size of the MW is in kDa.
3.4.2 Biochemical characterization of the hStau1dsRBD2-4 - ARF1 SBS20bp complex
EMSA assay was performed to confirm the formation of the hStau1dsRBD2-4 - ARF1 SBS20bp com-
plex and to determine the stoichiometry. hStau1dsRBD2-4 formed two distinct complexes at 1:1 and
1:2 (Fig. 3.11 B). Since hStau1dsRBD2-4 was shown to be monomeric in solution, the first shift might
correspond to one molecules hStau1dsRBD2-4 bound to one molecule ARF1 SBS20bp ; the second
shift might correspond either to one protein fragment bounds to two ARF1 SBS20bp molecules or
possibly to one molecule ARF1 SBS20bp bounds to two protein molecules.
SEC-MALLS analysis was performed to clarify the molecular mass of the complexes. In contrast to
the EMSA experiments, only one complex was present. The calculated molecular weight for the
hStau1dsRBD2-4 - ARF1 SBS20bp complex is 62 ± 4 kDa that corresponded to one protein molecule
(MW: 39,7 kDa) and two ARF1 SBS20bp molecules (MW: 12 kDa) (Fig. 3.11 A). This result was
consistent with the second shift present in the EMSA experiment.
FA measurements showed that hStau1dsRBD2-4 bound to the ARF1 SBS20bp with a KD of 10 ± 2
nM, in comparison to the Full-Length protein the affinity was reduced only by two-fold (Fig. 3.11 C).
This result indicated that the SSM, TBD, and dsRBD5 do not have a direct effect in mRNA binding
activity, but rather might be required to stabilize the protein in order to fulfill the mRNA binding
activity. Crystallization experiments were conducted to characterize the complex further, but no
crystals could be obtained.
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Figure 3.11. hStau1dsRBD2-4 formed stable complexes with ARF1 SBS in vitro (A) SEC-MALLS elution
profile of hStau1dsRBD2-4 in complex with the ARF1 SBS, the calculated molecular mass is indicated
in blue (B) EMSA analysis of the hStau1dsRBD2-4 interaction with the fluorescent label ARF1 SBS20bp
. The protein shifted the label ARF1 SBS20bp and formed two RNA complexes (black arrows). (C)
The bar graph shows the calculated binding affinity of the hStau1 FL and hStau1dsRBD2-4 for the single
ARF1 SBS20bp sense strand (light gray) and the double-stranded ARF1 SBS20bp (dark gray). The
calculated KD and their corresponding error (error bars) are the mean and the SD of a minimum ofthree
experiments. (Mean KD and SD in nM).
3.4.3 Reconstitution of the hStau1DNDC- ARF1 SBS complex
The reconstitution of the hStau1DNDC - ARF1 SBS complex had been performed as described
above using a 1:1.2 molar ratio (protein - RNA). Massive precipitation could be observed and
persisted despite various optimization attempts that include: incubation at RT or 4°C, resuspension
of both components in a high salt buffer, addition of glycerol or magnesium and dilution of the
protein before the addition of the ARF1 SBS with subsequent complex formation and concentration.
A final reconstitution attempt was performed in high salt buffer (300mM KCl). The reaction mixture
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was centrifugated and applied to an SEC column.
The hStau1DNDC - ARF1 SBS complex eluted as two separate peaks. The main peak shifted to the
left, and the 260/280 ratio was slightly increased suggesting RNA incorporation. The SDS-PAGE
showed a band corresponding to hStau1DNDC in the first eluted peak (Fig.3.12). Moreover, attempts
to concentrate the fraction of the main peak failed because of the persistent heavy precipitation.
Finally, due to precipitation no further characterization could be done with the hStau1DNDC - ARF1
SBS complex.
Figure 3.12. Representative SEC result of the hStau1DNDC-ARF1 SBS complex. (A) SEC profile of
the complex. Retention volume of the hStau1DNDC apo (black) and the complex with the ARF1 SBS
are indicated in the table (blue). There is no significant increase in the absorbance at 260 nm in the
first peak. (B) The Coomassie-stained SDS-PAGE shows the fractions that correspond to the peak I
containing the protein, peak II and III correspond to the unbound ARF1 SBS. Line I: Sample before SEC
run. The size of the MW is in kDa.
3.4.4 Reconstitution of the hStau1dsRBD3-5- ARF1 SBS complex
The recombinantly purified hStau1dsRBD3-5 was mixed with the ARF1 SBS in a ratio of 1:1.2, heavy
precipitation issues persisted after the components were mixed. The precipitation could be in part
overcome by resuspending hStau1dsRBD3-5 in 300mM KCl before the ARF1 SBS was added; in
this way, the precipitation could be in part overcome. After 1h incubation on ice, the complex was
centrifugated and subjected to SEC.
SEC experiments were performed with two different ionic strength conditions (100mM and 300mM
NaCl), to test the effects of the ionic strength dependent multimerization of hStau1dsRBD3-5 (referred
in section 3.2) in mRNA binding activity. In contrast to the FL protein, different ionic strength
conditions could be used to test the capability of the hStau1dsRBD3-5 fragment to bind the ARF1
SBS. The resulting profiles showed that hStau1dsRBD3-5 could bind ARF1 SBS in the two ionic
strength, but the stability of the complex is negatively affected by low ionic strength conditions. In
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both cases, the elution profile showed a broad peak that shifted to higher molecular weight. Further,
a significant increase of the 260/280 ratio confirmed complex formation in both cases (Fig. 3.13).
SDS-PAGE analyses showed that hStau1dsRBD3-5 was present in all fractions of the peaks. The
fractions corresponding to the main peak showed a second band that might correspond to the
dimer. This result suggested that hStau1dsRBD3-5 could form a stable complex with the ARF1 SBS
in vitro and the stability of the complex improve in a high ionic strength condition.
Figure 3.13. Representative SEC result of the hStau1dsRBD3-5-ARF1 SBS complex in two different ionic
strength conditions. Although for both experiments the same amount of protein was used, the peak
absorption is significantly higher in the 300mM SEC run as well as the complex yield after SEC. (A)
SEC profile of the hStau1dsRBD3-5 with the ARF1 SBS (300mM KCl), the complex elutes as a peak with
a shoulder on the left side. Retention volume of the hStau1dsRBD3-5 protein alone and the complex with
the 1ARF1 SBS are indicated in the table. (B) The Coomassie-stained SDS-PAGE exhibit a protein
band that extend through the peak and the shoulder. (C) SEC profile of the hStau1dsRBD3-5 with the
ARF1 SBS (100mM KCl). Retention volume of the hStau1dsRBD3-5 protein alone and the complex with
the ARF1 SBS are indicated in the table. (D) The Coomassie-stained SDS-PAGE shows the fractions
that correspond to the peak I. Line I shows the complex sample before SEC run. The size of the MW is
in kDa.
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3.4.5 Biochemical characterization of the hStau1dsRBD3-5 - ARF1 SBS20bp complex
EMSA experiments were performed to confirm hStau1dsRBD3-5 - ARF1 SBS complex formation
using the label ARF1 SBS20bp . hStau1dsRBD3-5 shifted the ARF1 SBS20bp and formed two protein
complexes species (Fig. 3.14 B), since the SEC-MALLS result of the hStau1dsRBD3-5 alone showed
that the protein was present as a monomer and dimer in solution; it could be possible that the two
complexes observed corresponded to a 1:1 and a 2:1 (protein:RNA) ratio. To further determine the
binding stoichiometries of the complexes, SEC-MALLS measurements were performed.
Figure 3.14. hStau1dsRBD3-5 formed stable complexes with ARF1 SBS in vitro (A) SEC-MALLS elution
profile of the hStau1dsRBD3-5 - ARF1 SBS complex, the calculated molecular mass is indicated in blue
(B) EMSA analysis of the hStau1dsRBD3-5 interaction with the fluorescent label ARF1 SBS20bp on
a native 6% Acrylamide gel. hStau1dsRBD3-5 shifted the label ARF1 SBS20bp and formed two RNA
complexes (black arrows). (C) The bar graph shows the calculated binding affinity of the hStau1 FL
and the hStau1dsRBD3-5 for the single ARF1 SBS20bp sense strand (light gray) and the ARF1 SBS20bp
(dark gray). The calculated KD and their corresponding error (error bars) are the mean and the SD of a
minimum of three experiments. (Mean KD and SD in nM).
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Examination of the SEC-MALLS data confirmed the existence of two complexes (Fig. 3.14 A). The
experimentally measured molecular masses for peak I and II were 75 ± 4 kDa and 104 ± 4 kDa
respectively. This result suggested that peak I might correspond to a complex with a binding ratio
of 1:2 (one protein molecule and two ARF1 SBS molecules) and peak II a second complex with a
binding ratio of 2:2 (two protein molecules and two ARF1 SBS molecules). To quantify the binding
affinity of the hStau1dsRBD3-5 for ARF1 SBS20bp , we performed FA experiments with the purified
hStau1dsRBD3-5 and the ARF1 SBS20bp . The calculated dissociation constant of KD: 9 ± 1 nM was
slightly weaker than the affinity of the FL protein. This result suggested that the N terminus region
included dsRBD2 had a minor or no effect in the mRNA binding activity of the hStau1 protein (Fig.
3.14 C).
3.4.6 hStau1dsRBD3-5 - ARF1 SBS complex crystallization
The purified hStau1dsRBD3-5 - ARF1 SBS complex was concentrated and subjected to crystallization
experiments. Preliminary crystals were observed in the Qiagen JSCG+, Qiagen PEGS, Qiagen
Nucelix, Hampton Research Index, and Morpheus screens (Fig. 3.15 A). Hexagonal-shaped plates
were obtained from an 8 mg/ml concentrated sample. Crystals grew in a period of 3 months.
Most of the crystals could be successfully reproduced, but the majority were too thin and small for
data collection, some crystals could be tested on the synchrotron beamline PXII of Swiss Light
Source (SLS) (Paul Scherrer Institute, Villigen, Switzerland). The best crystals diffracted about to
14 Å resolution. The grew time could be shortened by different optimization attempts including
micro-seeding. However, the crystal size still was not optimal for data collection.
Figure 3.15. Crystals of hStau1dsRBD3-5 - ARF1 SBS complex (A) Crystals obtained with the
hStau1dsRBD3-5 - ARF1 SBS complex. (B) Image of the best diffracting crystal (7 Å ).
Attempts to remove flexible regions at the C terminus of hStau1dsRBD3-5 (ca. 20 aa) yielded crystals
with the same morphology than the crystals obtained with the original hStau1dsRBD3-5 construct
and resulted in poor diffraction (>20 Å ). Further optimization was done by Christiane Emmerich
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(laboratory technician). Although crystals from different conditions were tested, the resolution of
the best diffracting crystals ranged from 9 to max. 7 Å (Fig. 3.15 B).
3.5 hStau1 dsRBD3 and 4 are sufficient for ARF1 SBS binding in
vitro
3.5.1 Reconstitution of the hStau1dsRBD3-4 - ARF1 SBS complex
In the crystals optimization process of the hStau1dsRBD3-5 - ARF1 SBS complex, we analyzed
some of the crystals on a SDS-PAGE and denaturing urea/acrylamide gel. The denaturing
urea/acrylamide gel verified that the ARF1 SBS still bound to hStau1dsRBD3-5. However, the
SDS-PAGE showed a single protein band between the 20 and 25 kDa marker suggesting that the
hStau1dsRBD3-5 construct undergo natural proteolytic degradation (Fig. 3.16 A) during crystalliza-
tion.
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Figure 3.16b. hStau1dsRBD3-5 undergo natural proteolytic degradation during crystallization (A) 20%
denaturing urea/acrylamide gel (left) and Coomassie-stained SDS-PAGE (right) of (I) dissolved crystals
of the hStau1dsRBD3-5 - ARF1 SBS complex, (II) sample of hStau1dsRBD3-5 - ARF1 SBS complex and (III)
sample of ARF1 SBS. The black arrow shows the degradation product present in the dissolved crystal.
(B) Coomassie-stained SDS-PAGE of the recombinantly purified hStau1dsRBD3-4. (C) MS analysis of
the degradation fragment corresponding to the dissolved crystal of the hStau1dsRBD3-5 - ARF1 SBS
complex (band indicated by the black arrow). The matched peptides correspond to 89% of the sequence
of the hStau1dsRBD3-4 construct.
The band that corresponded to the degradation product was further analyzed and characterized by
Mass spectrometry (TOPLAB GmbH). The mass spectrometry analysis identified the same region
that comprised the hStau1dsRBD3-4 construct (Fig. 3.16 B and C). Since mRNA binding activity
persisted after proteolysis of the hStau1dsRBD3-5 and the degradation product correspond to the
hStau1dsRBD3-4 construct, we focused our work on this construct. For this Christiane Emmerich
reconstituted the complex and conducted crystallization experiments.
Purified hStau1dsRBD3-4 was mixed with a 1.2 molar excess ARF1 SBS. The ARF1 SBS was
resuspended in 3M KCl to avoid precipitation issues. After incubation, the complex was subjected
to SEC. The elution profile was similar to the complex of hStau1dsRBD3-5 - ARF1 SBS. The complex
eluted as a broad peak with a shoulder on the right side, indicating some heterogeneity of the
sample. The retention volume shifted considerably to high molecular weight. Furthermore, the
260/280 ratio was significantly increased (Fig. 3.17 A). The SDS-PAGE of the peak fractions showed
that the protein is present in all fractions (Fig. 3.17 B). This data demonstrated that dsRBD3 and 4
are sufficient to bind ARF1 SBS in vitro.
Figure 3.17. Size exclusion chromatography of hStau1dsRBD3-4 in complex with the ARF1 SBS using
a Superdex 200 16/60 GL column. The size of the MW is in kDa. Line I shows the complex sample
before the SEC run. (A) SEC elution profile of hStau1dsRBD3-4 in complex with the ARF1 SBS. The
broader peak is significantly shifted, and the 260/280 ratio is increased considerably. Retention volume of
hStau1dsRBD3-4 apo (black) and the complex (blue) are indicated in the table. (B) The Coomassie-stained
SDS-PAGE loaded with the peak fractions (peak I) of the run show a single band of high purity.
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3.5.2 Biochemical characterization of the hStau1dsRBD3-4 - ARF1 SBS20bp complex
To further characterize the mRNA binding activity of hStau1dsRBD3-4 EMSA analysis was performed.
Similarly to hStau1dsRBD3-5, hStau1dsRBD3-4 bound to ARF1 SBS20bp as observed by a shift and a
supershift of the RNA band (Fig. 3.18 B). The binding stoichiometry of the complex was assessed
by SEC-MALLS experiments. The experimentally determined molar mass was 49 ± 3 kDa, which
corresponded to two molecules hStau1dsRBD3-4 and one ARF1 SBS20bp molecule in agreement
with the second shift of the EMSA experiments (Fig. 3.18 A).
The binding affinity was quantified by FA using the ARF1 SBS20bp . The hStau1dsRBD3-4 construct
bound the ARF1 SBS20bp with a KD of 14 ± 4 nM. The affinity was reduced more than two-fold
compared to the FL protein (Fig. 3.18 C). These data showed the possible role in mRNA binding
regulation mediated by dsRBD2 together with the TBD and dimerization region (SSM and dsRBD5).
Both regions could be required to fulfill the recognition and binding of targets mRNA more efficiently.
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Figure 3.18b. hStau1dsRBD3-4 formed stable complexes with ARF1 SBS in vitro (A) SEC-MALLS elution
profile of hStau1dsRBD3-4 in complex with the ARF1 SBS, the calculated molecular mass is indicated in
blue (B) EMSA analysis of the hStau1dsRBD3-4 interaction with the fluorescent label ARF1 SBS20bp on
a native 6% Acrylamide gel. The hStau1dsRBD3-4 shifted the label ARF1 SBS20bp and formed two RNA
complexes (black arrows). (C) The bar graph shows the calculated binding affinity of the hStau1 FL and
the hStau1dsRBD3-4 for the single ARF1 SBS20bp sense strand (light gray) and the ARF1 SBS20bp (dark
gray). The calculated KD and their corresponding error (error bars) are the mean and SD of a minimum
of three experiments. (Mean KD and SD in nM).
3.6 hStau1dsRBD3-4 recognizes and binds ARF1 SBS by
conformational readout of the minor and major groove.
3.6.1 hStau1dsRBD3-4 - ARF1 SBS complex crystallization
The purified complex was used for crystallization experiments. The complex crystallized in different
conditions. All crystals could be reproduced and promising conditions were optimized. The crystals
appeared after one day and showed a significant increase in size. Different crystals were tested at
the synchrotron beamline PXII of SLS. The best crystals diffracted to 3-2.9 Åresolution.
The collected data set was processed with the X-ray Detector Software (XDS) software (Kabsch,
2010). The images were index in the tetragonal space group P41 21 2 with unit cell dimensions of
a = b = 105.9 Å and c = 169.2 Å and a = b = g = 90°. The volume of the asymmetric unit (ASU)
contained one complex subunit. The structure of hStau1dsRBD3-4 - ARF1 SBS complex was deter-
mined at 2.9 Å resolution and solved by Molecular replacement (MR) using PHASER (McCoy et al.,
2007). The model was generated by the superposition of two known structures of Staufen dsRBD
(DmStau dsRBD5 PDB ID: 5CFF (Jia et al., 2015) and human hStau1 dsRBD5 PDB ID: 4DKK),
with this model two dsRBD3 molecules could be found. The density map that was obtained after
the first refinement cycles revealed an additional electron density on the back side of the structure.
This density was used to place a homology model of dsRBD4 manually, that was built using the
SWISS-MODEL server (swissmodel.expasy.org) (Arnold et al., 2005). The second dsRBD4 could
not be fitted in the electron density.
A seleno-methionine (SeMet) data set was collected to verify the exact arrangement of the three
dsRBDs found. The SeMet data set and the refined phases of the native crystal were used to
calculate difference Fourier map. Based on the difference Fourier map, it was possible to trace
the methionine sites of each dsRBD. From the 4 Met (Met213 for the two dsRBD3, Met321, and
Met348 in dsRBD4) present in the sequence four were identified (Fig. 3.19).
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Figure 3.19. Difference Fourier map of the hStau1dsRBD3-4-ARF1 SBS complex. Six methionine were
observed after SeMet substitution (M181 in dsRBD3 molecules A and B do not belong to the wild-type
sequence). The anomalous difference Fourier map of the complex contoured at 4s (shown in red) is
superimposed on the structure of the hStau1dsRBD3-4-ARF1 SBS complex. Met residues in dsRBD3
(molecules A and B) and in dsRBD4 are indicated.
After rebuilding and refinement in COOT and PHENIX, the Rwork was refined to 21.7% and the
Rfree to 24.0% with good stereochemistry. Five residues at the C terminus were missing from the
electron density map. Furthermore, the loop between dsRBD3 and 4, together with two loops in the
dsRBD4 were disordered in the structure. The final statistics for the structure were summarized in
the table 3.1.
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Table 3.1. Data collection and refinement statistics.
Native SeMet
ARF1 SBS-hStau1dsRBD3-4 ARF1 SBS-hStau1dsRBD3-4 ARF1 SBS
Data collection
Space group P41 21 2 P61 21 2 H32
Cell dimensions
a, b, c ( Å ) 105.9, 105.9, 169.2 79.9, 79.9, 237.3 43.8, 43.8, 452.1
a, b, g ( °) 90, 90, 90 90, 90, 120 90, 90, 120
Wavelength 1.045 0.980 1.000
Resolution ( Å ) 50-2.89 (3.06-2.89) 50-4.23 (4.48-4.23) 50-1.9 (2.02-1.90)
Rsym or Rmerge 0.133 (2.864) 0.274 (1.685) 0.089 (1.341)
I /sI 20.52 (1.32) 10.81(2.03) 13.52 (1.70)
Completeness (%) 99.4 (96.8) 99.7 (99) 99.9 (99.6)
Redundancy 27.5 (25.5) 27.7 (25.5) 10.3 (10.3)
CC(1/2) 100 (81.4) 100 (75.1) 100 (69.5)
Refinement
Resolution ( Å ) 47.35-2.89 38-1.9
No. reflections 40874 13828
Rwork / Rfree 21.7/24.0 24.4/26.2
No. atoms 4278 1883
Protein 3058
RNA 1217 1828
Water 3 40
B-factors (A^2) 109.7 54.4
Protein 126.7
RNA 77.4 53.5
Water 73.2 46.7
R.m.s deviations
Bond lengths ( Å ) 0.004 0.019
Bond angles ( °) 0.58 2.38
One native crystal for each construct and one SeMet crystal were used for data collection. Values in parentheses are for
the highest-resolution shell.
3.6.2 hStau1dsRBD3-4 - ARF1 SBS structure
A view of the structure is given in Fig. 3.20. In the structure, the ARF1 SBS was clamped in the
middle of the three dsRBDs. All three dsRBDs adopted the canonical abbba topology, where a
short a-helix 1 and a longer a-helix 2 were packaged against the hydrophobic face of the anti-
52
CHAPTER 3. RESULTS
parallel b-sheet. Hydrophobic interactions between the two a-helices with the b-sheet allowed a
tight packaging of the dsRBD structure, while at the same time this compact conformation allowed
charged residues to form a positively charged surface to recognize and bind the A-conformation of
the RNA.
Figure 3.20. Structure of the hStau1dsRBD3-4- ARF1 SBS complex (A) Cartoon representation of the
structure of the hStau1dsRBD3-4- ARF1 SBS complex. dsRBD3 molecules A and B are in blue, RNA is
in black. N and C terminus are indicated in both domains as well as secondary structure elements in
dsRBD3A. (B) Side view of the structure (145°rotation over the vertical axis). dsRBD4 is in cyan, N and
C terminus are indicated. The regions that are not visible in the electron density are represented as
dotted lines. (C) Top view of the structure (90°rotation over the horizontal axis).
The RNA recognition mode of the three dsRBDs was similar to that described for other dsRBD (By-
croft et al., 1995, Nanduri et al., 1998, Ryter, 1998, Ramos et al., 2000, Blaszczyk et al., 2004, Stefl
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et al., 2010, Jayachandran et al., 2015). The interaction surface on the RNA extended to the major
groove and the two successive minor grooves of the RNA. I used the Protein Interfaces Surfaces
and Assemblies (PISA) server, to analyze the interaction surfaces of the hStau1dsRBD3-4-ARF1
SBS complex.
Two individual dsRBD3 molecules (dsRBD3 molecule A and dsRBD3 molecule B referred to as
dsRBD3A and dsRBD3B respectively) were positioned in anti-parallel fashion along the ARF1 SBS.
The two dsRBD3 molecules dsRBD3A and dsRBD3B are very similar and therefore with a Root
Mean Square Deviation (RMSD) of 0.8 Å over 61 Ca atoms (residues 184- 253). dsRBD3A bound
the ARF1 SBS with a buried surface area of 8032 and had a complex-formation significance (CSS)
score of 1 (CSS ranges from 0 to 1 as the significance of the interface in complex formation)
indicating that the interaction surface is biological relevant and not a crystal-packing artifact. In
contrast, dsRBD3B had a smaller binding surface (586,2 Å ) nevertheless the CSS scored 0.6, this
indicates that the interaction surface of dsRBD3B is also biologically significant.
Only one dsRBD4 was visible in the electron density map. In the structure, dsRBD4 interacted with
dsRBD3A and with the ARF1 SBS. dsRBD4 bound the ARF1 SBS with a buried surface area of
444 Å (PISA CSS score 1). The electron density for the second dsRBD4 was not visible. Binding
of the missing dsRBD4 with the RNA can be excluded because steric clashes with the already
bound dsRBD4 limited the interaction. The missing electron density also suggested that the second
dsRBD4 molecule could be unbound and disordered. PISA analysis of the interaction between
dsRBD4 and dsRBD3A indicated that the interface region involved a 273 Å2 (5,1 %) area. The
CSS score for this interface was 0.01, suggesting that the interaction might not be of biological rele-
vance. Four hydrogen bonds contributed to the interactions between the domains (Fig.3.21 A) and
engaged mainly the b-strand 1 of dsRBD3A and the a- helix 2 of dsRBD4. To determine the effect
of this interaction in mRNA-binding activity, we mutated two residues involved in the interactions
(hStau1dsRBD3-4 N197A, R342A) and performed FA experiments with the hStau1dsRBD3-4 N197A,
R342A mutant. The apparent affinity of the mutants for ARF1 SBS was similar to the wild-type
hStau1dsRBD3-4, indicating that the mRNA-binding activity of the domains was not influenced by the
inter-domain interaction (Fig. 3.21 A and B).
The linker segment connecting dsRBD3 and 4 was not visible in the electron density map, suggest-
ing that this 29 amino acid long linker might be flexible. Sequence-based calculations predicted
that the length of the inter-domain linker varied from 100 to 120 Å . This distance could be plausible
to connect the dsRBD4 with any of the dsRBD3. The residues present in the linker were mainly
positively charged (27% of the residues in the linker were positively charged) of these six are
lysines and two arginines and play a role in mRNA-binding activity. To determine the impact of the
inter-domain linker in binding affinity, we designed two mutants and measured the binding affinity by
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FA experiments. One mutant was designed to alter the length of the linker and the second mutant
was designed to reduce positive charge of the linker.
Figure 3.21. dsRBD3A and dsRBD4 interaction interface (A) Side view of the structure with a close-up
view of the interaction interface between dsRBD3A and dsRBD4. Interacting residues are shown
as sticks. Hydrogen bonds are indicated as dashed lines. Resides mutated for FA experiments are
underlined. (B) The bar graph shows the calculated binding affinity of the hStau1dsRBD3-4 construct and
the designed mutants (interface mutant, length linker mutant, and linker composition mutant) for the
single 20 nt ARF 1 mRNA sense strand (light gray) and the double-stranded 20 bp ARF 1 mRNA (dark
gray). The calculated KD and their corresponding error (error bars) are the mean and SD of a minimum
of three experiments. (Mean KD and SD in nM).
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When the linker region (amino acid 254 to 283) was replaced with a GSSGSGSS sequence, the
affinity for ARF1 SBS was reduced more than eightfold compared to the wild-type protein (Fig.3.21
B). However, when four lysins of the linker were mutated to alanine, the affinity for ARF1 SBS was
decreased only by three-fold. These results indicated that the inter-domain linker contributed to
RNA binding. Both the length of the linker and also the amino acid composition might stabilize the
binding between the two dsRBD with the ARF1 SBS.
3.7 The ARF1 SBS structure is A-form in conformation
3.7.1 ARF1 SBS crystallization
To address the conformational changes of the ARF1 SBS upon binding, we crystallized and deter-
mined the apo-state ARF1 SBS structure at a resolution of 1.9Å . The images were processed with
the XDS software (Kabsch, 2010). The structure of the ARF1 SBS was solved by MR using a 19
bp A-form RNA as a model (PDB: 1QC0 Klosterman P.S. (1999)). The crystal lattice corresponded
to the trigonal space group (R32) H32, with unit cell parameters a = b = 43.8 Å and c = 452.1 Å and
a = b = 90°g = 120°. In this space group, the ASU comprised one and a half RNA molecules (fig.
3.22 A). The model exhibited a pseudo-infinite helix along the c-axis (fig. 3.22 B). The 19bp length
of the ARF1 SBS induced six statically disordered conformations (Lazzaretti et al., 2018). The
refinement of the model yielded a Rfree of 26.2% and a Rwork of 24.4% with good stereochemistry.
The final statistics for the structure were summarized in the table 3.1.
56
CHAPTER 3. RESULTS
Figure 3.22b. Structure of the apo-state ARF1 SBS (A) On the left structure of the ARF1 SBS. GU
wobble base pairs are in gray. On the right, an asymmetric unit consisting of one complete ARF1 SBS
molecule plus halve ARF1 SBS molecule. (B) View of the crystal packing where the pseudo-infinite
helix extends through the c-axis. All RNA and protein structure figures were generated with PyMOL.
The ARF1 SBS structure has a canonical A-form double-stranded helices with blunt ends. The
RNA contains 17 Watson-Crick base-pairs and two G-U wobble base pairs. The C1´-C1´distance
of the two wobble pairs (10.2Å and 10.3Å ) did not differ of the average distance of Watson-Crick
base-pairs (10.5Å (Seeman et al., 1976)). The glycosidic bond angle between the C1´ sugar atom
and the base was different from the ~54°angle of Watson-Crick base-pairs (Fig. 3.23). Still, the
two wobble base pairs did not significantly distort the RNA-backbone.
Figure 3.23. Glycosidic angle and distance of the C1´-C1´ of the two wobble pairs present in the ARF1
SBS structure. Bases are shown as sticks. Hydrogen bonds are indicated as dashed lines. Distance
between the ribose C1’ atoms and gycosidic bond angles are indicated in black. (A) Interaction of the
wobble pair G86-U201. (B) Interaction of the wobble pair G79-U208.
3.7.2 ARF1 SBS conformational changes by binding to hStau1dsRBD3-4
The superposition of the apo and bound ARF1 SBS structures showed an RMSD of 1.32 Å . This
low RMSD value indicated that the RNA underwent barely significant conformational changes upon
protein binding. Although bound ARF1 SBS retained the characteristic A-conformation, numerous
sites in the RNA revealed slight differences. The binding of hStau1dsRBD3-4 led to elongation of the
ARF1 SBS. Consequently, the major groove widened to facilitate interactions between the a-Helix
2 of both dsRBD3 and the RNA backbone (Fig. 3.24 A). Additionally, the interaction between the
b1-b2 loop of dsRBD3A and the ARF1 SBS induced a deviation of 3.9 Å at the 5´end and 3´end of
the sense strand (Fig. 3.24 A). Further changes in the bound structure were the bending of the
helical axis of the symmetry-related RNA molecule bounded by stacking end to end. This favorable
stacking arrangement formed a semi-continuous major/minor groove conformation that allows the
b1-b2 loop of dsRBD3B to interact with the subsequent ARF1 SBS molecule (Fig. 3.24 B).
57
CHAPTER 3. RESULTS
Figure 3.24. ARF1 SBS conformational changes by binding to hStau1dsRBD3-4 (A)Superposition of the
structure of the unbound ARF1 SBS (deep salmon) and in complex with hStau1dsRBD3-4 (black) in the
same orientation. The RMSD is indicated. (B) Structure of the hStau1dsRBD3-4 - ARF1 SBS complex
and the simetry-realted ARF1 SBS molecule.
3.8 hStau1dsRBD3-4 recognition mode of ARF1 SBS
The structure of the hStau1dsRBD3-4 - ARF1 SBS complex showed that hStau1dsRBD3-4 bound over
nearly the entire length of the ARF1 SBS. The three visible dsRBDs primarily recognized and
bound the backbone through three different regions. Region 1 corresponded to a-helix 1, region 2
was present in the loop between b1 and b2 strand and region 3 located in the N-terminal end of
a-helix 2. The recognition mode observed in the structure was similar to those described for other
crystal structures of dsRBD-RNA complexes (Ryter, 1998, Ramos et al., 2000, Blaszczyk et al.,
2004, Stefl et al., 2010). Interestingly, all three domains exhibited direct interactions with G:C base
pairs. These interactions included direct and water-mediated hydrogen bonds (Fig. 3.25 and 3.26).
Region 1
In Region 1, polar and charged residues of the a-helix 1 made hydrogen bonds with both strands in
the minor groove of the ARF1 SBS primary (Fig. 3.25 and 3.26 region 1). In dsRBD3A residues
K183, S184, S187, and E191 formed hydrogen bonds with the ribose groups of U88 (20OH0), G200
(20OH), and U201 (O40). Another binding contribution was observed at the C-terminus of a-helix
1. Residue K195 formed a salt bridge with the phosphate group of C90 stabilizing the interaction
of a-helix 1 (Fig. 3.26 A). In addition to the non-sequence specific contacts, a sequence directed
58
CHAPTER 3. RESULTS
interaction was formed between S187 and G200. The side chain of S187 was hydrogen bonded to
the N2 of G200 through a water molecule (Fig. 3.25 D). dsRBD3B showed similar interactions as
dsRBD3A. The side chains of S184, S187, and E191 made hydrophobic contacts with A84 (O40),
G83 (20OH0), and U205 (20OH0) (Fig. 3.26 A). The sequence-specific interaction of S187 was also
present in this domain. As in molecule A, the side chain of S187 made a water-mediated hydrogen
bond with the N2 of G83 (Fig. 3.25 C). dsRBD4 contacted the minor groove only through polar
residues of a-helix 1 (Fig. 3.26 B). The side chains of N286, S289, Q293, and Q296 were hydrogen
bonded to the ribose groups of A199 (O40), C198 (20OH0), C91 (O40), and C91 (20OH0) respectively.
The NE2 atom of Q293 docked into the minor groove of the ARF1 SBS to come in a closed position
to the O2 of C90 (Fig. 3.25 B).
Region 2
In region 2 the minor groove of the ARF1 SBS was recognized by the loop connecting the b1 and
b2 strands (Fig. 3.25 and 3.26 region 2). The GPxHxx motif of dsRBD3A contacted the minor
groove at base G77 and U211. In dsRBD3A, the backbone of P211 was in hydrogen bonding to
the exocyclic amino group of G77 (Fig. 3.25 E). In addition, the ribose 20OH0 group of U211 was
hydrogen-bonded to the side chain of H212. In dsRBD3 B residues, P211 and H212 were close to
the minor groove formed by base stacking interaction with the symmetry-related RNA molecule, but
specific hydrogen bonds could not be observed. In contrast, the loop between the b1 and b2 strand
of dsRBD4 did not interact with the minor groove and appeared to be partially unstructured.
Region 3
The positive charged surface in region 3 of all dsRBDs interacted with the sugar-phosphate back-
bone of the major groove (Fig. 3.25 and 3.26 region 3). The conserved motif, KKxAK in region3 of
dsRBD3 A and RBD3 B all three Lys (K234, K235, and K238) contacted the RNA (Fig. 3.26 A). The
side chain of K234 formed a salt bridge with the backbone of G80 (molecule A) and G197 (molecule
B); while it simultaneously formed a hydrogen bond with the O30 atom of G79 (molecule A) and
G196 (molecule B9). Besides, the amide proton of K234 was hydrogen-bonded to the phosphate of
G79 (molecule A) and G196 (molecule B). The side chain of K235 protruded into the major groove
and interacted with the RNA backbone by electrostatic interactions. In contrast, the electron density
of this Lys was not well defined in molecule B. Finally, the last Lys K238 formed a salt bridge with
the phosphate group of U201(molecule A) and A84 (molecule B) (Fig. 3.26 A).
In dsRBD4 four residues made contact with the RNA backbone. The side chain of N336 was
hydrogen-bonded to the phosphate group of C81. The conserved K337 was packaged parallelly
to the sense strand to form a hydrogen-bond with the ribose of C81 as well as a salt bridge with
the phosphate group of A82. At the same time, the main chain formed a hydrogen bond with the
phosphate group of C81. The second Lys (K338) of the conserved motif was interacting with the
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phosphate group of G200 by a hydrogen-bond and salt bridges. Finally, the last Lys K341 formed
a salt bridge with the phosphate group of A199, bridging the two RNA strands across the major
groove (Fig. 3.26 B).
Figure 3.26. Recognition of the ARF1 SBS by hStau1dsRBD3-4 (A) Front view and (B) side view of the
structure. Interaction region in dsRBD3A, dsRBD3B and dsRBD4 are indicated in the structure (Region
1: a-helix 1, region 2: loop between b-strand 1 and 2 and region 3: a-helix 2). For each region, an
extended view of the side chain residues interacting with the RNA is shown. Side chains and bases are
shown as sticks. Dashed lines indicate hydrogen-bonds.
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3.8.1 Structure-based mutational analyses of hStau1dsRBD3-4 ARF1 SBS
Three mRNA binding regions in dsRBD were identified through biochemical and structural studies
of dsRBD-RNA complexes (Bycroft et al., 1995, Kharrat et al., 1995, Nanduri et al., 1998, Ryter,
1998, Ramos et al., 2000). Substitution of residues within these regions either severely reduced
RNA binding or entirely abolished the dsRNA binding (Bycroft et al., 1995, Kharrat et al., 1995,
Nanduri et al., 1998, Ryter, 1998, Ramos et al., 2000). For the Staufen protein, biochemical and
structural data of the complexes of DmStaufen dsRBD3 bound to an artificial 12 bp stem-loop
identified five highly conserved residues present in region 2 and 3 essential for RNA-binding activity
in vitro (Ramos et al., 2000). In the structure of the hStau1dsRBD3-4 - ARF1 SBS complex four of
these residues in dsRBD3A and B were implicated in dsRNA recognition (H212 in region 2 and
K234, K235, K238 in region 3). In the case of dsRBD4, only residues in region 3 were present
(K337, K338, and K341 in region 3). We wanted to analyze the significance of the residues present
in the binding regions of the two domains for the ARF1 SBS binding and to determine the effect of
a base directed read-out of the minor groove in the context of a physiological target. For this, we
designed and generated a set of mutations in both domains.
Figure 3.27. Circular Dichroism (CD) spectra of (A) the hStau1 FL, the sequence specific mutants, (B)
hStau1dsRBD3-4 and mutants set used for the FA analysis.
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One set of mutations encompassed all three regions of dsRBD3 (region 1: I186A, S187A, region
2: H212A, K214A and region 3: K234A, K235A, K238); a second set included region 2 and 3 of
dsRBD3 and dsRBD4 (dsRBD4 region 2: R315A, R317A and region 3: K337A, K338A, K341A)
and, the third set comprised region 3 in dsRBD4. Finally, for the last mutant construct, all three
residues that contribute to the direct base recognition were mutated to alanine. The same amino
acid substitution was tested in the context of the FL protein (Fig. 3.27 and 3.28). All mutants were
expressed and purified as the wild-type protein and eluted as a mono-monodispersed peak in SEC
(Data not shown). Dr. Daniela Lazzaretti performed Circular Dichroism (CD) analysis of the purified
mutants. The CD spectra of the mutants did not show any significant conformational changes (Fig.
3.27). This data indicated that a possible reduction or loss of dsRNA binding activity was not a
consequence of protein fold destabilization. With FA experiments we determined the dissociation
constant of the mutants with the ARF1 SBS20bp .
Mutations in all three regions of dsRBD3 showed a stronger effect on mRNA binding affinity. In
this mutant, ARF1 SBS20bp binding is reduced more than 14-fold (Fig. 3.28 Set 1). However,
mutations in only two regions of the dsRBD3 exhibited a less severe effect on mRNA binding (8-fold)
(Fig. 3.28 Set 2 top construct). Mutations in region 2 and 3 of dsRBD4 showed a considerable
reduction of 4-fold in binding affinity, whereas a mutation only in region 3 had a even milder effect
on dsRNA binding (3-fold) (Fig. 3.28 Set 2 bottom to construct and set 3). This data indicated that
mutations in dsRBD3 showed a significant reduction in ARF1 SBS binding, but did not entirely
abolish mRNA binding activity. At the same time, mutations in dsRBD4 had a less drastic effect
on mRNA binding. Altogether, these results stressed the significance of the interplay of the two
domains in the complete recognition and interactions of the ARF1 SBS.
The hStau1dsRBD3-4 direct base recognition mutant had a modest effect in binding affinity with a
KD of 22 ± 2 nM (1.6-fold), the same direct base recognition mutations in the context of the FL
protein had a stronger effect in RNA binding affinity with a 3-fold reduction (KD of 18 ± 2 nM) in
comparison with the wild-type protein (Fig. 3.28). These results suggested that the hStau1 binding
affinity forARF1 SBS was mainly mediated by sequence-independent interactions, whereas the
observed base directed interactions had a minor contribution in binding. These residues might
provide a mechanism of fine-tuned substrate identification.
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Figure 3.28. Fluorescence anisotropy assay with interactions mutants. The bar graph shows the
calculated binding affinity of hStau1 FL, the hStau1dsRBD3-4 construct and the sets of designed mutants
for the single 20 nt ARF1 SBS sense strand (light gray) and the double-stranded 20 bp ARF1 SBS (dark
gray). The calculated KD and their corresponding error (error bars) are the mean and SD of a minimum
of three experiments. (Mean KD and SD in nM).
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4 Discussion
Based on the biochemical analysis we could elucidate some insights of the mRNA binding proper-
ties of hStau1, and by structural analysis as well as structure-based mutagenesis, the molecular
principles of dsRNA recognition of dsRBD3 and 4 of hStau1 bound to the ARF1 SBS.
Protein dimerization and oligomerization is a common mechanism in proteins to regulate their
function (Marianayagam et al., 2004). Different dsRBPs had been shown to dimerize or multimerize
to activate and execute diverse functions. This is the case of Xlrbpa, PACT, ADAR2, PKR, TRBP,
and hStau1 (Daher et al., 2001, Hitti et al., 2004, Lemaire et al., 2005, Valente and Nishikura, 2007,
Martel et al., 2010, Gleghorn et al., 2013). hStau1 was shown to dimerize and multimerize in vitro
and in vivo (Martel et al., 2010, Gleghorn et al., 2013). hStau1 dimerization depended on the
SSM and dsRBD5 regions of the protein with a minor contribution assigned to dsRBD2 (Martel
et al., 2010, Gleghorn et al., 2013). Consistently, our data confirmed the findings that the main
multimerization region resided in the C-terminus of hStau1. In contrast, we could not detect dimer-
ization activity induced by dsRBD2; even the lack of this domain did not affect dimerization. It is still
possible that heterophilic interactions between dsRBD2 and 5 contribute to hStau1 self-association.
The presented SEC and SEC-MALLS assays indicate also that hStau1 can also co-exist in a
monomer-dimer population in solution. This result is consistent with studies in living cells where
hStau1 monomers have been shown to interact in order to form larger complexes in vivo (Martel
et al., 2010). It is not clear, however, which factor or conditions determine and regulate dimerization
and the biological function of hStau1 dimerization.
hStau1 binds ARF1 SBS in vitro independently from the dimerization domain
Previous studies identified a conserved 19 bp stem within the ARF1 30-UTR as a specific hStau1
binding side in vivo. In this thesis, I have demonstrated that hStau1 could directly interact with
the ARF1 SBS and form a stable complex in vitro. hStau1 showed high affinity not only for the
physiological target ARF1 SBS but also for DmStau targets (bcd III and bcd Vb) and randomly
RNA substrates that contain secondary structures and predominant GC content. This is consistent
with the hStau1 binding preference for RNA duplex substrates (Johnston et al., 1992, Ferrandon
et al., 1994, Mallardo et al., 2003, Kim et al., 2005, Furic et al., 2007, Kim et al., 2007, LeGendre
et al., 2012, Heraud-Farlow et al., 2013, Laver et al., 2013, Ricci et al., 2013, de Lucas et al., 2014,
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Sugimoto et al., 2015).
Based on the biochemical analysis of the different hStau1 truncated constructs, we concluded that
dsRBD3 and 4 are the minimum structure capable of binding the ARF1 SBS. This is consistent with
previous studies that identified dsRBD3 and 4 as the minimal region that binds dsRNA (Johnston
et al., 1992, Marión et al., 1999, Wickham et al., 1999, Luo et al., 2002). Deletion of dsRBD2
and dsRBD5 did not affect RNA binding activity, suggesting that dimerization of the hStau1 is not
necessary for RNA binding activity in vitro.
However, the semi-quantitative EMSA analysis showed that all hStau1 truncated constructs formed
two distinct complexes in solution independently of the dimerization region. Although ARF1 SBS
was described as a specific target, hStau1 apparently binds simultaneously at different regions of
the ARF1 SBS. This suggests alternative binding modes of hStau1 and endorses the idea that
hStau1 recognize primary structural elements rather than the ARF1 SBS sequence. Furthermore,
it has been reported that additional hStau1-bound duplexes are present in the ARF1 30-UTR
(Sugimoto et al., 2015).
It is tempting to speculate that the dsRNA targets of hStau1 could have a primary function in the
formation of hStau1 contained mRNP by interacting simultaneously with multiples hStau1 that
because of the proximity dimerize or oligomerize. hStau1 oligomerization could lead to structural
rearrangements that position other dsRBDs such as dsRBD2 for hStau1 and hStau2, or dsRBD1
for DmStau and hStau2, in an orientation that allows the recognition of larger binding motifs or other
secondary structures within the mRNA. Thus, Stau could regulate more accurately the affinity but
also the specificity of its targets. This idea is consistent with the observations that Stau is involved
in the formation of mRNP by regulating different targets or by binding to varying regions into the
same RNA target (Ferrandon et al., 1994, Micklem, 2000, Duchaîne et al., 2002, Mallardo et al.,
2003, Thomas et al., 2005, Kretz et al., 2012).
hStau1 dsRBD3 and 4 adopt the canonical dsRBD fold
Our structure revealed that the fold of hStau1 dsRBD3 and 4 resemble the canonical dsRBD with
some differences at the helix a1. In comparison to other dsRBD, helix a1 is the region with the
highest sequence variability (Masliah et al., 2012). Structural superposition of hStau1 dsRBD3
and 4 with other dsRBD presents in the protein data bank revealed two characteristic helix a1, an
elongated and a shorter helix a1 (Fig. 4.1).
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Figure 4.1. Comparison of the structures of RNA-bound dsRBDs. All structures were aligned using
the secondary-structure elements b1b2b3a2. Supeposition of hStau1 dsRBD3A (dark blue),dsRBD3B
(blue, rmsd 0.213 Å) and dsRBD4 (cyan, rmsd 0.723 Å), PDB: 6HTU (Lazzaretti et al., 2018)) with
representative RNA bound dsRBD structures present in the protein data bank. Close up view of the
helix a1 (rotated by 90°). The dsRBD of hStau1 (dsRBD3), ADAR2 (dsRBD1), Xlrbpa, and RNase
III exhibit a longer helix a1. The position of the extended helix a1 is similar in all dsRBD, except for
ADAR2 dsRBD1 that adopts a different angle (dotted lines, top panel). In contrast, hStau1 dsRBD4,
ADAR2 dsRBD2, and both dsRBD of NF90 have a shorter version of helix a1 (bottom panel). Structures
used: Xenopus laevis Xlrbpa dsRBD (lemon, rmsd 0.513 Å), PDB: 1DI2 (Ryter, 1998). Aquifex aeolicus
RNase III dsRBD (beige, rmsd 0.621 Å) PDB: 2NUF (Gan et al., 2006). Rattus norvegicus ADAR2
dsRBD1 (dark rose, rmsd 0.848 Å) and dsRBD2 (rose, rmsd 0.792 Å), PDB: 2L3J (Stefl et al., 2010).
Mus musculus NF90 dsRBD1 (dark green, rmsd 0.738 Å), dsRBD2 (green, rmsd 0.583 Å), PDB: 5DV7
(Jayachandran et al., 2015).
The helix a1 of hStau1 dsRBD3 as well as ADAR2 dsRBD1, Xlrbpa dsRBD2, and Aquifex aeoli-
cus RNase III dsRBD is extended by one turn (Ryter, 1998, Gan et al., 2006, Stefl et al., 2010).
Meanwhile, helix a1 of hStau1 dsRBD4, ADAR2 dsRBD2, NF90 dsRBD1 and 2 is shorter (Stefl
et al., 2010, Jayachandran et al., 2015). As a consequence of the shorter helix a1, the subsequent
loop is longer and may be more flexible. This structural variation of helix a1 could be a determinant
factor in the specific RNA recognition by dsRBD given that helix a1 participate in recognition of the
dsRNA minor groove.
ARF1 SBS recognition by hStau1 dsRBD3 and 4
The recognition mode of hStau1 dsRBD3 and 4 resemble the canonical binding mode, observed in
other dsRBD - dsRNA complexes (Ryter, 1998, Ramos et al., 2000, Stefl et al., 2010, Jayachandran
et al., 2015, Masliah et al., 2018). In the structure, two dsRBD3 were bound to the RNA in an anti-
parallel arrangement, and one dsRBD4 wrapped one side of the ARF1 SBS. The mode of binding
of the molecules of dsRBD3 demonstrated that this domain used three canonical mRNA binding
regions to recognize the A-conformation of the physiological ARF1 SBS target. Superposition of
the two dsRBD3 domains presented in the structure revealed that only b1–b2 loop in dsRBD3 (in
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the canonical RNA binding region two) adopted different conformations to engage the minor groove
of the ARF1 SBS. This conformational change is an indication of how the flexibility of the b1–b2
loop could be used by the domain to recognize different targets.
In our structure, the only visible dsRBD4 engaged just two regions to bind the ARF1 SBS (canoni-
cal region one and three). In this domain, the b1–b2 loop was not visible in the electron density
supporting the idea that region two of dsRBD4 might adopt different conformations to screen
between different secondary structures of the mRNA target. This is consistent with other dsRBD
- dsRNA complexes in which this b1–b2 loop was disordered (Ryter, 1998) or demonstrated by
the relaxation properties of this region in DmStau in NMD data (Ramos et al., 2000, Castrignanò
et al., 2002). Mutations of conserved residues in hStau1 involved in RNA binding in region two
and three of dsRBD4 confirmed that dsRBD4 mutants affected RNA binding affinity less than the
corresponding mutations in dsRBD3 in FA experiments. Consistently, previous studies showed
weaker RNA-binding activity of dsRBD4 in comparison with dsRBD3 in filter binding assays (Wick-
ham et al., 1999, Luo et al., 2002). It is plausible that the weak binding of dsRBD4 could facilitate
a transient interaction with the RNA for screening the RNA for the correct SBS and subsequently
induce anchoring of dsRBD3. This idea is supported further by the finding that hStau1 exhibited
sliding activity on mRNA targets in vivo (Wang et al., 2015).
As for other dsRBD domains, our structural and mutagenesis data showed that the dsRNA recogni-
tion mode of hStau1 is primarily determined by non-sequences specific interactions with the RNA
backbone. This reinforced the idea that the recognition mode of dsRBD is primarily determined
by the dsRNA A-form conformation (Ryter, 1998, Chang and Ramos, 2005, Stefl et al., 2005). In
addition, dsRBD3 exhibited a base-specific interaction mediated by helix a1 at the minor groove.
This interaction was present in the two dsRBD3 molecules in the structure. Ser187 bound the amino
group of G200 and G83 (for molecule A and B respectively). These interactions are water-mediated
and possibly the result of an adaptation of the helix a1 to induce a specific binding. Two other
dsRBD containing proteins ADAR2 and NF90 in complex with RNA exhibited sequence-specific
interactions with a Met at the corresponding position (Stefl et al., 2010, Jayachandran et al., 2015).
The b1–b2 loop of dsRBD3A mediated the next additional sequence-specific interaction at the
subsequent RNA minor groove. Here, the backbone of Pro211 interacted with the exocyclic amino
group of G77. Similar sequence-specific interactions by b1–b2 loop have been described for
other dsRNA-dsRBD complexes (Ryter, 1998, Chang and Ramos, 2005, Stefl et al., 2005, 2010,
Jayachandran et al., 2015).
The base-directed contacts mediated by hStau1 helix a1 and b1-b2 loop favor GC base pairs.
The structure revealed that the base-directed interactions involved the guanine amino group of
the GC pair. Thus, AU base pairs would be probably discriminated against GC. The principal
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reason is the absence of hydrogen bond donor/acceptor of AU base pairs at the minor groove.
This could constrain not only the interactions with the protein but also allowed discrimination over
GC pairs. At the same time, it is likely that the domain would fail to discriminate between base
pairs reversal GC or CG because of the relative same center position of the amino group in both
cases (Seeman et al., 1976). Mutation of the residues involved in base-directed interactions
showed no significant effect on RNA binding in FA. However, in the context of the FL protein,
a small negative effect on mRNA binding activity could be observed, suggesting that two GC
pairs in the continuous minor groove of the ARF1 SBS A-conformation contribute to ARF1 SBS
readout by hStau1. Although the contribution to the overall binding affinity of the GC recognition
by helix a1 and b1–b2 loop for the binding was negligible, it could be critical for target discrimination.
Comparison of the hStau1dsRBD3-4 - ARF1 SBS structure with the DmStau dsRBD3 - 12 bp
stem-loop complex
Figure 4.2. Superposition of hStau1 dsRBD3A - ARF1 SBS complex (dsRBD3A dark blue, ARF1 SBS
black) with the structures of DmStau dsRBD3 - 12 bp stem-loop (dsRBD3 darkred, stem-loop light gray).
For each region, an extended view of the side chain residues interacting with the RNA is shown. Side
chains are shown as sticks. Common interacting residues are colored salmon. Structures used: DmStau
- 12 bp stem-loop complex (NMR State 33), PDB: 1EKZ (Ramos et al., 2000). hStau1 dsRBD3A - ARF1
SBS complex, PDB: 6HTU (Lazzaretti et al., 2018).
Globally, the crystallographic structure of hStau1 dsRBD3A complexed with the ARF1 SBS resem-
bles the NMR structure of the complex between DmStau dsRBD3 and a 12 bp stem-loop RNA
(Fig. 4.2 RMSD 2.31 Å ). Surprisingly, the optimized stem-loop RNA can adopt a similar fold as the
ARF1 SBS despite a 7 bp difference and the presence of a tetraloop. For this, the tetraloop mimics
the fold and shape of a consecutive minor groove. As a consequence, most of the residues involved
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in the binding pointed toward the same recognition region as in the dsRBD3A - ARF1 SBS structure.
DmStau dsRBD3 and dsRBD3A adopt a similar conformation. Some differences arise from the
position of b1–b2 loop and the angle of helix a1. On the first minor groove (Fig. 4.2 Region 2),
b1–b2 loop of dsRBD3A is pulling toward the bases to interact with the GC pair. In contrast, DmStau
dsRBD3 b1–b2 loop is less flexed to extends over the minor groove and interact with the RNA
backbone. Both domains use the same conserved residues in b1–b2 loop to interact with the minor
groove. DmStau dsRBD3 exhibited an additional contact as a consequence of the extension of the
loop over the groove. In region 3, the same conserved residues in DmStau and hStau1 dsRBD3
interact with the major groove similarly by binding across the major groove (Fig. 4.2 Region 3).
Significant differences are seen in region 1. The different angle of DmStau helix a1 is an induced fit
caused by the different geometry of the tetraloop in comparison with the minor groove of the ARF1
SBS duplex. The conformation of the loop extends the binding surface allowing a reorientation of
DmStau helix a1. This reorientation of DmStau helix a1 facilitates more extensive contacts with the
RNA as for the hStau1 helix a1. A conserved Ser in helix a1 (DmS581- C, hS187 - G) is the only
common residue that mediates a base directed interaction in both complexes (Fig.4.2 Region 1).
Two additional residues in the DmStau helix a1 Glu and Ile (E585 and I588) make base contacts
through stacking and van de Waals interactions. The equivalent Glu in hStau1 helix a1 (E191)
mediate a nonspecific interaction with the RNA. The other residues involved in the RNA interaction
maintain and stabilize the position of helix a1 by interacting with the RNA backbone. Consistently,
DmStau helix a1 exhibited more contacts as hStau1 helix a1 due to the tetraloop fold.
Comparison of the hStau1dsRBD3-4 - ARF1 SBS structure with other dsRBD/RNA Complexes
Comparison of the structure of dsRBD3A with other dsRNA-dsRBD complexes (where direct read
out of the RNA minor groove is also achieved by helix a1 and b1–b2 loop) revealed a similar mode
of binding (Fig. 4.3 ). However, the flexible conformations of the b1–b2 together with sequence vari-
ability and orientation of helix a1 confer each dsRBD with domain specific binding. The variations
in helix a1 and b1–b2 loop led to differences in the number of bases between these regions that in
turn determine a different "register length" to discriminate between targets (Ryter, 1998, Ramos
et al., 2000, Chang and Ramos, 2005, Stefl et al., 2005, 2010, Masliah et al., 2012, Jayachandran
et al., 2015). In principle, dsRBD could discriminate longer RNA substrates by the interplay of two
or more dsRBD. For example, DmStau and hStau2 have three and four dsRBD, respectively that
bind RNA (Johnston et al., 1992, Ramos et al., 2000, Micklem, 2000, Heber et al., 2019). It is
possible that the proteins could recognize not only more extended regions but also tertiary struc-
tures into the same RNA. Additionally, a certain grade of influence in target discrimination is also
attributed to further secondary structures present in the dsRNA that could alter the binding regis-
ter of the Stau protein through dimerization as in the case of bcd in DmStau (Ferrandon et al., 1994).
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Figure 4.3. Superposition of hStau1 dsRBD3A (dark blue) with structures of RNA bound dsRBDs that
exhibit sequence-specific recognition mediated by helix a1 and b1–b2 loop. Residues involve in the
interactions are shown as sticks. Bases in direct contact with the dsRBD are highlighted in white. The
register length is determined by the x number of bases in between of the base directed interactions.
Structures used: Aquifex aeolicus RNase III dsRBD (beige, RMSD 0.621 Å) PDB: 2NUF (Gan et al.,
2006). Rattus norvegicus ADAR2 dsRBD1 (dark rose, RMSD 0.848 Å) and dsRBD2 (rose, RMSD 0.792
Å), PDB: 2L3J (Stefl et al., 2010). Mus musculus NF90 dsRBD1 (dark green, RMSD 0.738 Å), dsRBD2
(green, RMSD 0.583 Å), PDB: 5DV7 (Jayachandran et al., 2015)
Dr. Daniela Lazzaretti introduced directed mutations in the DmStau protein to test the in vitro and in
vivo significance of the interactions determined by the structural data. For the DmStau-FA analysis,
the stem-loop III from bcd 3´UTR was used to test the affinity in the context of a physiological target.
The FA data of the DmStau1 RNA-backbone-binding mutants support the apparent dominance
of dsRBD3 over dsRBD4 in RNA-binding activity observed for hStau1 (Lazzaretti et al., 2018).
Consistently in vivo dsRBD3 mutation of residues interacting with the RNA backbone (conserved
residues H606A and K608A in region 2; K628E and K629A in region 3) could not rescue the
Stau-null phenotype; quite contrary to the similar mutations in dsRBD4 that restore the Staufen
phenotype. These result, raise the question if other domains of the DmStau compensated the
dsRBD4 mutation effect or if the function of dsRBD4 is not essential for RNA binding, but it could
be important in other regulatory mechanisms later in development as for dsRBD2 and 5 with osk
(Ferrandon et al., 1994, Micklem, 2000).
Interestingly, base-directed mutations in either dsRBD3 or 4 (S581 and Q718 corresponding to
S187A and Q293A in hStau1 respectively) had a mild effect in vitro but exhibited a clear additive
negative effect in rescue experiments in vivo. These observations suggest that shape-specific,
as well as sequence-specific recognition, are essential for the RNA binding activity of the Stau
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protein. At the same time, these results showed that the in vitro determined binding affinity of Stau
is insufficient to predict the biological affinity or specificity. It will be necessary to take account not
only affinity distribution methods with different dsRNA duplexes (in vitro) but also hiCLIP methods
(in vivo) to have a more global and accurate view of the biological affinity and specificity of Stau.
The here present data evidence the promiscuous binding nature of Stau a protein that was de-
scribed to be mostly shape-specific than sequence-specific. However, it has been shown in different
species that Stau regulates various specific targets in different stages of development (St. Johnston
et al., 1989, Johnston et al., 1991, 1992, Broadus and Doe, 1997, Broadus et al., 1998, Ephrussi
et al., 1991, Ferrandon et al., 1994, Fuerstenberg et al., 1998, Kim-Ha et al., 1995, Li et al.,
1997, Schuldt et al., 1998, Kiebler et al., 1999, Duchaîne et al., 2002, Macchi et al., 2004, Vessey
et al., 2012, Kusek et al., 2012). It is still unclear how the promiscuous binding of Stau can fit the
specific requirements in a biological context. Our in vitro and in vivo measurements, as well as
the complex structure, are probably not sufficient to answer this question. Tough our data indicate
that although each hStau1 domain (dsRBD3 and 4) can mediate a shape-dependent and a base
directed recognition, is the interplay of them both what accomplish full RNA binding and probably a
more accurate sequence-specific recognition. This interdependency between the domains could
be the regulatory factor that connects the promiscuous- and the specific-binding nature of Stau.
Consequently, the affinity and specificity context is likely to be affected by the presence of multiple
dsRBDs that can bind RNA. So is the case of DmStau or hStau2 where further dsRBD (dsRBD1
in DmStau, dsRBD1 and 2 in hStau2) could enhance binding affinity (Heber et al., 2019) but also
contribute to the discrimination of larger substrates.
Based on previously published data and the presented thesis, a possible model of RNA recognition
by Stau integrates the RNA binding ability and specificity of the active canonical dsRBD. In this
model, a minimum of two canonical dsRBDs mediate dsRNA binding, where a "low-affinity" dsRBD
is compensated by a "high-affinity" dsRBD that specifically recognized the RNA substrate. We
speculate that the "low-affinity" dsRBD first screens the dsRNA substrate to find GC pairs at the
minor groove; for this, the protein could slide over the RNA as previously reported (Wang et al.,
2015). That way the "high-affinity" dsRBD could be accommodated at the binding sites, where the
specific register length is expected, to accomplish full recognition and binding.
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5 Materials and Methods
5.1 Materials
5.1.1 Chemicals
Standard chemicals that are not listed here were purchased from Sigma-Aldrich, Germany, Merck,
Germany or Roth, Germany.
Table 5.1. List of chemicals used for this thesis
Chemical Supplier
Acetic acid Merck, Germany
Agarose Standard, for electrophoresis Roth, Germany
Ampicillin sodium salt Roth, Germany
Ammonium persulfate (APS) Sigma-Aldrich, Germany
Ammonium sulfate ((NH4)2SO4) Merck, Germany
Boric acid Merck, Germany
Bovine serum albumin (BSA) Sigma-Aldrich, Germany
Bradford assay reagent Bio-Rad, Germany
Bromphenol Blue sodium salt Sigma-Aldrich, Germany
Calcium chloride dihydrate Merck, Germany
Complete Protease Inhibitor, EDTA-free Roche, Germany
Di-Potassium hydrogen phosphate (K2HPO4) Merck, Germany
1,4-Dithiothreitol (DTT) Biomol
Ethanol, absolut VWR
Ethylene glycol SERVA, Germany
Glycerol, 86 % Sigma-Aldrich, Germany
Glycerol, 100 % Merck, Germany
Guanidine hydrochloride Roth, Germany
Hydrogen chloride (HCl) VWR
Imidazole, low UV-absorption Merck, Germany
Isopropyl-b-D-1-thiogalactopyranoside (IPTG) Roth, Germany
Isopropanol VWR
Kanamycin sulfate SERVA, Germany
Magnesium chloride hexahydrate Fluka, Switzerland
Magnesium sulfate (MgSO4) VWR
Methanol VWR
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Chemical Supplier
2-Mercaptoethanol (b-ME) Roth, Germany
PhastGel Blue R-350 GE Healthcare, Germany
Polyethylene glycol 200-35000 Sigma-Aldrich, Germany
Polyethylene glycol 3350 Sigma-Aldrich, Germany
Potassium chloride (KCl) Merck, Germany
Potassium di-hydrogen phosphate (KH2PO4) Sigma-Aldrich, Germany
Rotiphorese® Gel 30 (29.2% acrylamide, Roth, Germany
0.8% N,N’-methylene-bis-acrylamide)
SafeViewTM Nucleic Acid Stain Gentaur
Sodium dodecyl sulfate (SDS) Roth, Germany
Sodium hydroxide (NaOH) Merck, Germany
Sodium chloride (NaCl) VWR
Spectinomycin-2HCl pentahydrate SERVA, Germany
Tetramethylethylendiamin (TEMED) Triton X-100 Fluka, Switzerland
Triton X-100 Merck, Germany
Trizma® base Roth, Germany
TRIzol® Sigma-Aldrich, Germany
Merck, Germany Invitrogen, Germany
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) Roth, Germany
5.1.2 Buffer solution
Milli-Q water was used, for the preparation of all buffers. The pH was adjusted by titration with 37%
HCl or 10 M NaOH. The prepared buffers were then filter-sterilized (0.22 µm) or autoclaved.
Table 5.2. List of buffers used for this thesis
Buffer Composition
10£TBE 0.89 M Tris pH 8.0, 0.89 M Boric Acid, 25 mM EDTA
10£SDS running buffer 250 mM Tris pH 6.8, 2 mM Glycine, 1% (w/v) SDS
5£SDS loading buffer 250 mM Tris pH 6.8, 8% (w/v) SDS, 10% (v/v) b-ME, 30%
(v/v) Glycerol, 0.02% (w/v) Bromophenol blue
Destaining solution 40% (v/v) ethanol, 20% (v/v) acetic acid
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5.1.3 Consumables
Table 5.3. List of chemicals used for this thesis
Consumable Supplier
Amersham Hybond-P PVDF membrane GE Healthcare, Germany
Clear Sealing Tape 3M Hampton Research, USA
ClearVue™ Sealing Sheets Molecular Dimensions, UK
CleneGlass™ Coverslips Molecular Dimensions, UK
Concentrators (Amicon Ultra) Millipore, USA
Crystallization plates MRC, 96 well, sitting drop Molecular Dimensions, UK
Dialysis membranes Spectra/Por, USA
Electroporation cuvettes Bio-Rad, Germany
Eppendorf safe-lock micro test tubes 1.5 ml and 2 ml Eppendorf, Germany
Mounted Cryo loops 3M Hampton Research, USA
Sterile filters 0.22 µm, 0.45 µm Sarstedt, Germany
Syringes Braun, Germany
Tubes (15 ml and 50 ml) Greiner-Bio-One, Germany
24-well plates, "Linbro style” Molecular Dimensions, UK
Weighting dishes Roth, Germany
5.1.4 Culture media
All types of media and additional buffers were sterilized by autoclaving (121°C, 20 min) before
usage. Components were dissolved in deionized and filtered water. The media used in this work
are listed in table 5.4.
Table 5.4. Culture media
Medium
LB medium (for 1 l) 10 g Tryptone
5 g Yeast extract
Sodium chloride
TB medium (for 0.9 l) 12 g BactoTM Tryptone
24 g BactoTM Yeast extract
4.7 mL Glycerol, 86 %
After cooling down, 100mL Potassium phosphate buffer (0.17 M
KH2PO4, 0.72 M KH2PO4 ) is added.
ZY medium (for 0.93 l) 10 g Tryptone
5 g Yeast extract
After cooling down, 1 mL MgSO4 (1 M), 20 mL 5052 (50£) and 50 mL
NPS (20£) is added.
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5.1.5 Resins and columns
Table 5.5 lists the resins and columns used routinely in this thesis.
Table 5.5. Beads and columns
Beads and column types Name Supplier
Cobalt beads HIS-Select® Co Affinity Gel Sigma-Aldrich, Germany
Nickel beads Ni-NTA Agarose Qiagen, Germany
Cation exchange beads Macro-Prep® High S Support Bio-Rad, Germany
Gelfiltration HiLoadTM 16/60 SuperdexTM 200 GE Healthcare, Germany
5.1.6 Enzymes, Kits and Markers
All enzymes, Kits and Markers used in this work are listed in table 5.6
Table 5.6. Enzymes, commercial kits and markers
Type Name Supplier
Bovine serum albumin (BSA) Sigma-Aldrich, Germany
DNA marker 1 kb DNA Ladder NEB
100 bp DNA Ladder NEB
Ligase T4 DNA Ligase Thermo Scientific, Germany
Plasmid preparation Qiagen, Germany Plasmid Midi
Kit
Qiagen, Germany
Polymerase Pfu DNA Polymerase Thermo Scientific, Germany
Proteases Trypsin Sigma-Aldrich, Germany
Subtilisin Sigma-Aldrich, Germany
GluC Roche, Germany
Elastase Sigma-Aldrich, Germany
TEV Home-made, recombinant
Protein marker PageRuler Prestained Protein
Ladder
Thermo Scientific, Germany
Pierce Unstained Protein MW
Marker
Thermo Scientific, Germany
PageRuler Unstained Protein
Ladder
Thermo Scientific, Germany
Restriction enzymes BamHI-HFTM NEB
NdeI NEB
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5.1.7 Crystallization screens
Table 5.7. List of crystallization screens used for this thesis
Consumable Supplier
Classics Suite, PEGs Suite, PEGs II Suite, Qiagen, Germany
PACT Suite, Nucleix Suite, JCSG+ Suite
Additives, Index, SaltRX, Hampton Research, USA
complex screen 1, complex screen 2 MPI-Martinsried Crystallization Facility
Crystal platform Magic 1 , AJ1, Morpheus
5.1.8 Technical equipment
All devices used in this work are listed in table 5.8
Table 5.8. Technical equipment
Machine Name Manufacturer
Chromatography system ÄKTAprime plus GE Healthcare, Germany
Dispensing robot mosquito® crystal TTP Labtech Ltd, UK
Electroporator MicroPulserTM Bio-Rad, Germany
Gel system Mini-PROTEAN® Tetra Cell Bio-Rad, Germany
Homogenizer M-110L Pneumatic Microfluidics
Incubator Heraeus® Thermo Scientific, Germany
Phosphorimager Phosphorimager Typhoon
8600
GE Healthcare, Germany
Pipettes Pipetman Eppendorf, Germany
Power supplies Power supplies Bio-Rad, Germany
Screen optimizer dragonfly® crystal TTP Labtech Ltd, UK
Shakers Innova® Laboratory Shakers New Brunswick
Sonicator Sonopuls HD 3100 Bandelin
Spectrometer NanoDrop 2000 Thermo Fisher Scientific, USA
Microtip MS 73 Bandelin
Tabletop centrifuge Centrifuge 5424 Eppendorf, Germany
Tabletop centrifuge, refrigerated Centrifuge 5415 R Eppendorf, Germany
Allegra® X-15R Beckman Coulter
Thermocycler MJ MiniTM Thermal Cycler Bio-Rad, Germany
Thermomixer Thermomixer comfort Eppendorf, Germany
Ultracentrifuge, refrigerated Avanti® J26XPI Beckman Coulter
Ultracentrifuge rotors JA-25.50 Beckman Coulter
JLA-8.1000 Beckman Coulter
JLA-16.250 Beckman Coulter
77
CHAPTER 5. MATERIALS AND METHODS
5.1.9 Bacterial strains
E. coli strains were used for plasmid production and protein expression. Transformation of plasmids
was carried out using electroporation.
Table 5.9. E. coli strains used for cloning and protein expression
Genotype and Characteristics Supplier
E.coli XL1-Blue endA1 supE44 thi-1 hsdR17 recA1
gyrA96 relA1 lac [F’ proAB lacIq
Z¢M15 Tn10 (Tetr)]
Typical host strain for cloning
applications and for DNA
preparations; can be used in
blue-white colony screenings.
Stratagene
E.coli BL21 (DE3) Gold F° ompT hsdS(rB° mB°) dcm+
Tetr gal l (DE3) endA Hte
Features the phenotype which
increases transformation efficiency
over BL21; can be used for DNA
preparations.
Stratagene
E.coli BL21 (DE3) Star F° ompT hsdSB (rB° mB°) gal
dcm rne131 (DE3)
RNase deficient strain; reduction in
mRNA degradation and increase
the yield of recombinant protein
Invitrogen, Germany
5.1.10 Oligonucleotides
Primers used for cloning contain a NdeI site prior to an ATG start codon in the forward primer and a
BamHI site after the TAA stop codon in the reverse primers. All primers used in this work are listed
in table 5.10
Table 5.10. Primer sequences used for mutagenesis
Name Sequence 5´ -> 3
STAU _co 182-end mut for GGCGAAAACCTTTACTTCCAGGGCCATATGAACAAGAGCGAAATTTCTCAGGTC
STAU _co 182-end mut rev GACCTGAGAAATTTCGCTCTTGTTCATATGGCCCTGGAAGTAAAGGTTTTCGCC
STAU _co 360-end mut for CTGGGCTTCAAAGTTCCGCAGCGTCAATAAGGATCCTAATAGTCTAGAGCTAGC
STAU _co 360-end mut rev GCTAGCTCTAGACTATTAGGATCCTTATTGACGCTGCGGAACTTTGAAGCCCAG
STAU _co 70-end mut for GGCGAAAACCTTTACTTCCAGGGCCATATGAGCATTACCCCGACGGTCGAACTG
STAU _co 70-end mut rev CAGTTCGACCGTCGGGGTAATGCTCATATGGCCCTGGAAGTAAAGGTTTTCGCC
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5.1.11 RNA oligonucleotides
For the RNA interaction experiments we ordered the ARF1 SBS, the 5´-fluorescein-labeled ARF1
SBS20bp and the tested RNA strands from Integrated DNA Technologies, Inc.(IDT).
Table 5.11. RNA oligonucleotides used for RNA interaction experiments
Name Sequence 5´ -> 3
ARF1 SBS sense GAGUGCCAGAAGCUGCCUC
ARF1 SBS antisense GAGGCAGUUUCUGGUACUC
ARF1 SBS antisense (pc) GAGGCAGcUUCUGGcACUCA
ARF1 SBS20bp sense UGAGUGCCAGAAGCUGCCUC
ARF1 SBS20bp antisense GAGGCAGUUUCUGGUACUCA
PolyU20 (U20) U20
PolyUA10 (UA10) UA10
PolyUC10 (UC10) UC10
PolyUG10 (UG10) UG10
20 bp ARF1 hairpin UGAGUGCCAGAAGCUGCCUCCGUAAU GAGGCAGUUUCUGGUACUCA
GC-rich hairpin GAGGCAGUUUCUGGUACUCA
K10 TLS CUUGAUUGUAUUUUUAAAUUAAUUCUUAAAAACUACAAAUUAAG
K10 TLS (2xGC) CGCUUGAUUGUAUUUUUAAAUUAAUUCUUAAAAACUACAAAUUAAGCG
bcd III GGGCGCUAUUCGCCUUAGAUGUAUCUGGGUGGCUGCUCCACUAAAGCCC
GGGAAUAUGCAACCAGUUACAUUUGAGGCCAUUUGGGCUUAAGCG
bcd Vb CCCAAAAUGAAAAAUGUUUCUCUUGGGCGUAAUCUCAUACAAUGAUUACC
CUUAAAGAUCGAACAUUUAAACAAUAAUAUUUGGG
5.1.12 Software
Table 5.12. RNA oligonucleotides used for RNA interaction experiments
Software Reference
Coot Emsley and Cowtan, 2004; Emsley et
al., 2010
GraphPad Prism GraphPad Software, Inc., USA
PyMOL Schrödinger, LLC (2015)
XDS Kabsch, 2010
5.2 Methods
5.2.1 Nucleic acid methods
DNA amplification
The human Staufen 1 protein sequence was ordered as a codon-optimized construct in the pnC57
plasmid from GenScript. The hStau1 codon-optimized gene was amplified by Polymerase chain
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reaction (PCR) using Pfu DNA Polymerase (Thermo Scientific, Germany) according to the instruc-
tions of the manufacturer. The PCR product was analyzed by agarose gel electrophoresis (1.5%
w/v containing 1 x SYBR Safe DNA Stain (Invitrogen)) and purified from the gel using QIAquick Gel
Extraction Kit (Qiagen, Germany). The DNA was resuspended in 30 µl H2O.
Cloning in pET-MCN vectors
The amplified hStau1 codon-optimized gene was cloned into a pET-MCN vector. For this purpose
pET-MCN vectors with an N-terminal GST tag and with a hexahistidine (His) tag were linearized
using restrictions enzymes NdeI and BamHI (NEB, Germany) and incubated for 2-3 h at 37°C (table
5.13). The digested vectors were loaded into an agarose gel and further purified using QIAquick
Gel Extraction Kit (Qiagen, Germany). The extracted DNA vectors were resuspended in 30 µl H2O.
Table 5.13. Restriction digest of pET-MCN vectors
Component Volume
pET-MCN vector 150-200 ng
10x NEBuffer IV 5 µl
NdeI 1 µl
BamHI 1 µl
BSA 0.5 µl
ddH2O to 50 µl
Ligation
The ligation was performed with the T4 DNA Ligase (Thermo Scientific, Germany) and according to
the manufacturer’s instructions. For the ligation, 100ng of the digested pET-MCN vector was mixed
with two ro five fold molar excess of the DNA insert. The reaction was incubated for 2h at 20°C or
overnight at 16°C.
Transformation in E.coli
For transformation purpose, circa (ca.) 150 ng DNA were mixed with 50 µl electro-competent E.
coli cells on ice. The cells were subjected to a 4.8 ms pulse of 2.5 kV in an ice-cold electroporation
cuvette. Afterward, the cells were resuspended in 300µl of LB medium and incubated for 1 h at
37°C while shaking. The transformed cells were streaked out on an agar plate containing the
selective antibiotics and incubated over night at 37°C.
Plasmid preparation and verification
A single colony from the grown LB-agar plate was isolated and used to inoculate 5mL LB medium
with the correct antibiotics. The cultures were grown overnight at 37°C while shaking. Plasmid pu-
rification was performed using QIAGEN Plasmid Midi Kit (Qiagen), according to the manufacturer’s
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instructions. All plasmids were sequenced to verify the cloning success (Sequence Core Facility
MPI in Tübingen).
Site-directed mutagenesis
To generate the shorter constructs and to introduce point mutations site-directed mutagenesis was
performed. To this end, complementary oligonucleotide primers were designed that contain the
desired deletion or base substitution and ordered from Integrated DNA Technologies, Inc.(IDT).
The reaction mixture for a typical PfuUltra high-fidelity DNA polymerase-based PCR are shown in
table 5.14.
Table 5.14. Mutagenesis reaction
Component Volume
Plasmid DNA 100-150 ng
10x PfuUltra HF reaction buffer Buffer 5 µl
dNTPs (10 mM each dNTP) 1 µl
sense oligonucleotide primer (2µM) 1 µl
antisense oligonucleotide primer (2µM) 1 µl
PfuUltra HF DNA polymerase (2.5 U/µl) 1 µl
ddH2O to 50 µl
Parameters in the amplification program such as temperature and number of cycles were adjusted
according to the oligonucleotide primers and plasmid template. The methylated parental plasmid
was digested with 1µl DpnI enzyme for 3h at 37°C. Finally, 5µl of the mutagenesis reaction was
transformed into 50µl of E.coli XL1-Blue strain.
5.2.2 Recombinant protein expression in Escherichia coli
Pull-down experiments
Pull-down experiments were performed to analyze the solubility of the protein and to determine
the best conditions to produce high amounts of recombinant hStau1. For this, different cell strains
(E.coli BL21 (DE3) Star, E.coli BL21 (DE3) Star and E.coli BL21 (DE3) Plyss) and media (LB-,
TB- and ZY-medium) were tested. 20 mL cultures were inoculated and incubated at 37°C while
shaking until the optical density (OD600) reached 0.6 for LB and TB media and 2 for the ZY medium.
The cultures were cooled to 20°C while shaking. In the case of the LB and TB culture, 0.1 mM
Isopropyl-b-D-thiogalactopyranoside (IPTG) was added to induce protein expression. The cultures
were incubated for 16 to 18 h. For each culture two samples of 2ml were centrifugated. The pellet
was resuspended in lysis buffer (Table 5.15) and briefly sonicated (Bandelin Sonoplus, tip VS70T,
pulse ON/OFF 0.2/0.2, 25% amplitude, Bandelin electronic, Berlin, Germany).
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After centrifugation, the supernatant was incubated with the preequilibrated gel (Glutathione
Sepharose 4B for GST tagged proteins and HIS-Select Cobalt Affinity Gel for HIS tagged proteins)
for 1h under constant agitation. The gel was centrifugated (500g for 1min) to remove the super-
natant and washed three times with the lysis buffer. The washed gel was stained with SDS loading
dye and loaded on SDS-PAGE.
Large-scale expression
The large-scale expression was performed using the conditions found to be suitable in the expres-
sion optimization screen to produce high amounts of recombinant protein. Typically E.coli BL21
(DE3) Star cells were grown in 6L of TB medium containing the corresponding antibiotic at 37°C
while shaking. The large-scale expression was performed using the conditions found to be suitable
in the expression optimization screen to produce high amounts of recombinant protein. Typically
E.coli BL21 (DE3) Star cells were grown in 6L of TB medium containing the corresponding antibiotic
at 37°C while shaking. For SeMet substituted protein expression, E.coli DL41 (DE3) cells were
grown in 3L 1X M9 mineral medium (37.4 mM NH4Cl, 44.1 mM KH2PO4, and 95.8 mM anhydrous
Na2HPO4) supplemented with 0.4% w/v glucose, 40 µg/ml amino acids (with seleno-L- methionine
instead of methionine), and 1 µg/ml vitamins (riboflavin, niacinamide, pyridoxine monohydrochloride,
and thiamine) and antibiotics.
The pre-cooled cells (20°C) were induced with 1mM IPTG when the OD600 reached 0.6-0.7. The
protein expression was carried out at 20°C for 16-18h. The cells were harvested by centrifugation
(4000rpm 20min) and the supernatant discarded. The pellets were frozen in liquid Nitrogen and
stored at -80°C until further use.
5.2.3 Protein methods
All protein purification procedures were conducted at 4°C and performed on an ÄKTA purification
systems (GE Healthcare). All buffers were prepared with deionized H2O and filtered (0.22 µm).
Purification buffers used in this work are listed in table 5.15.
Determination of protein concentration
Protein concentration was determined by the Bradford assay (Bradford, 1976). A suitable volume of
recombinant protein (1- 20µl) was diluted with Milli-Q H2O to a final volume of 800µl and mixed with
200µl of Bradford solution. After 5 min incubation at RT, the absorbance of the recombinant protein
was measured at the wavelength 595nm on a spectrophotometer. The concentration of each
sample was determined using the calibration curve according to its absorbance by interpolation
(Bradford, 1976).
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Denaturing SDS-Gelelectrophoresis
According to the protein size, proteins samples were analyzed on 10% or 12% SDS-polyacrylamide
gels. The samples were mixed with protein loading buffer and heated at 95°C for 5min. The
samples were loaded into the gel with an unstained protein marker and run in 1x running buffer at
200V until the bromophenol blue border nearly run out the gel. The SDS-PAGE was rinsed with
water and incubated in Coomassie staining solution for 10-15min and subsequently destained.
Recombinant protein purification
The purification protocol consists of three steps: first affinity enrichment AC (by Cobalt Affinity
Gel or Glutathione Sepharose media), followed by IEX and SEC. An extended wash with lysis
buffer (1-1.2M NaCl) after affinity gel binding was introduced to reduce the nucleic acids that are
bound to the protein and could bias further experiments. All steps were monitored and analyzed by
SDS-PAGE.
The cell pellets were re-suspended in lysis buffer supplemented with EDTA-free protease inhibitor
and lysed by two passes through a microfluidizer (18,000 psi). The lysate was centrifugated to
remove cell debris (18000rpm for 1h). The supernatant was carefully collected and filtered using
a 5 µm filter. The filtered lysate was added to the pre-equilibrated affinity chromatography media
(Glutathione Sepharose 4B for GST tagged proteins and HIS-Select Cobalt Affinity Gel for HIS
tagged proteins) and incubated for 1h by constant agitation.
The slurry was packed into a column and connected to the ÄKTA purification systems. The column
was washed with 10 column volume (CV) of lysis buffer or until the UV absorbance at 260 nm
significantly sank and equilibrated with 5 to 10 CV AC buffer. Depend on the tag the recombinant
protein was eluted either with a linear gradient to 300 mM imidazole for HIS-tagged constructs
(5.15 HIS-AC elution buffer) or with a linear gradient to 40 mM reduced glutathione (5.15 GST-AC
elution buffer). The recombinant protein was dialyzed against dialysis buffer (5.15), and Tobacco
Etch Virus (TEV) protease was added to cleave the tag (HIS or GST).
The cleaved protein was loaded on a HiTrap CaptoS and washed with 10 CV IEX buffer. The
recombinant protein was then eluted from the cation-exchanger using a gradient to 100% NaCl (IEX
elution buffer). As a final purification step, the protein was subjected to SEC on a pre-equilibrated
HiLoad 16/600 Superdex 200pg column (GE Healthcare) with GF buffer.
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Table 5.15. Purification buffer hStau1 and truncated constructs
Construct Buffer composition
hStau1 FL
AC
HIS Lysis buffer 20mM Tris-HCl pH 7.5 at 4°C, 1M NaCl, 1mM
b-Mercaptoethanol
AC buffer 20mM Tris-HCl pH 7.5 at 4°C, 300mM NaCl, 1mM
b-Mercaptoethanol
AC elution buffer Affinity buffer supplemented with 300mM Imidazol
GST Lysis buffer 20mM Tris-HCl pH 7.5 at 4°C, 1M NaCl, 1mM DTT
AC buffer 20mM Tris-HCl pH 7.5 at 4°C, 300mM NaCl, 1mM DTT
AC elution buffer Affinity buffer supplemented with 40mM reduced glutathionel
IEX
Dialysis and 20mM Tris-HCl pH 7.5 at 4°C, 300mM NaCl, 1mM DTT
IEX buffer
IEX elution buffer 20mM Tris-HCl pH 7.5 at 4°C, 1.2M NaCl, 1mM DTT
SEC or GF
GF buffer 20mM HEPES pH 7.5 at 4°C, 150mM NaCl or KCl, 1mM DTT
hStau1
truncations
AC
HIS Lysis buffer 20mM Tris-HCl pH 7.5 at 4°C, 1M NaCl, 1mM
b-Mercaptoethanol, 5mM Imidazol
AC buffer 20mM Tris-HCl pH 7.5 at 4°C, 100mM NaCl, 1mM
b-Mercaptoethanol, 5mM Imidazol
AC elution buffer Affinity buffer supplemented with 300mM Imidazol
GST Lysis buffer 20mM Tris-HCl pH 7.5 at 4°C, 1M NaCl, 1mM DTT
AC buffer 20mM Tris-HCl pH 7.5 at 4°C, 100mM NaCl, 1mM DTT
AC elution buffer Affinity buffer supplemented with 40mM reduced glutathionel
IEX
Dialysis and 20mM Tris-HCl pH 7.5 at 4°C, 100mM NaCl, 1mM DTT
IEX buffer
IEX elution buffer 20mM Tris-HCl pH 7.5 at 4°C, 1.2M NaCl, 1mM DTT
SEC or GF
GF buffer 20mM HEPES pH 7.5 at 4°C, 150mM KCl, 1mM DTT
Affinity chromatography (AC), Ion exchange chromatography (IEX), size exclusion chromatography (SEC) or gel filtration
(GF).
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Circular dichroism spectroscopy (CD)
CD measurements of hStau1 and mutants were recorded on a Jasco J-810 spectropolarimeter in
the spectra range 190–240 nm, at 20°C. All measurements were performed with a protein concen-
tration of 0.2 mg/ml in the CD buffer (Table. 5.16). The average mean spectrum was calculated
from data of five scans.
Table 5.16. Protein methods buffers
Method Buffer composition
CD CD buffer 20 mM Tris–HCl, pH 7.5, at 4°C, 150 mM KCl
SEC-MALLS SM buffer 20 mM Tris–HCl, pH 7.5 AT RT, 150 mM KCl
Complex CR buffer 20 mM Tris, pH 7.5, at 4°C, 100 mM KCl, 1 mM DTT
reconstitution
FA FA buffer 20 mM HEPES, pH 7.5 at RT, 150 mM KCl
EMSA TG buffer 25 mM Tris, 192 mM Glycine pH 9.78 at RT
NG loading buffer 2.5X TG buffer, 50% Glycerol
Circular dichroism (CD), Fluorescence Anisotropy (FA), native gel (NG).
Complex reconstitution
For complex reconstitution, the recombinantly purified protein was resuspended in high salt buffer
(>300mM to 3M KCl) to prevent precipitation. The ARF1 SBS was purchased from IDT. The sense
and antisense strands were resuspended in deionized and sterilized H2O and mixed equimolarly.
The ARF1 SBS were heated at 95°C for 5 min and cooled to RT. The annealed ARF1 SBS was
resuspended in CR buffer (Table. 5.16) and mixed in a ratio 1:1.2M (RNA excess) with the purified
protein. The complex was incubated at 4°C for 1h, centrifuged and injected onto a pre-equilibrated
HiLoad 16/600 Superdex 200pg column (GE Healthcare) with CR buffer.
SEC-MALLS
SEC-MALLS was performed using a Superdex 200 Increase 10/300 GL column (GE Healthcare).
light scattering (LS) intensity at three angels was measured on a miniDAWN TREOS detector (Wyatt
Technologies, Santa Barbara, USA) operating at 659nm and refractive index (RI) was monitored
with an Optilab T–rEX differential refractometer (Wyatt Technologies). The equilibration of the
system and the runs were performed with the SM buffer (Table. 5.16). For each construct, the
sample volume injected into the systems was: 200 µg for hStau1 FL, 430 µg for hStau1dsRBD3-4,
400 µg for hStau1dsRBD2-4, and 350 µg hStau1dsRBD3-5. For the RNA–protein complexes, 140
µg of each construct was mixed with a 1.2 M excess of ARF1 SBS. The collected data were
recorded and analyzed using the protein conjugate procedure implemented in ASTRA software
(Wyatt Technologies).
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Fluorescence Anisotropy
The binding affinity of hStau1 FL and mutants were determined by fluorescence anisotropy using
50-6-fluorescein amidite (FAM)-labeled RNA at RT (19–21°C). The 50-6-FAM-labeled sense strand
and unlabeled antisense strand were purchased from IDT (The sequence are listed in Table. 5.12)
and annealed as described before (Complex reconstitution). Fluorescence polarization and intensity
were measured in an Infinite F200 plate reader (Tecan). The excitation and emission wavelength
were set to 485 nm and 535 respectively.
For the anisotropy measurements, 10nM of label RNA were incubated with increasing concentra-
tions of purified protein in FA buffer (Table. 5.16). The binding reactions were incubated for 10min
at RT in a total volume of 50 µl. Each titration point was consecutively scanned three times, with an
integration time of 40 µs. The anisotropy data was analyzed using Prism 6 software (GraphPad).
The KD was calculated with the anisotropy average by nonlinear regression fitting to the following
equation:
Y = Yf + (Yb °Yf ) · L+Kd +X °
p
(L+Kd +X )2°4 ·L ·X
2 ·L
where L = concentration of labeled RNA, X = protein concentration, Yf = anisotropy of free RNA =
(X = 0), and Yb = anisotropy of bound RNA (Fluorescence Polarization Technical Resource Guide,
fouth edition, Invitrogen).
Electrophoretic Mobility Shift Assay
EMSAs experiments were performed with the 50-6-FAM-labeled dsRNA. Typically, 1µM of 50-6-
FAM-labeled dsRNA was mixed with increasing concentration of purified protein (hStau1 FL and
mutants) in a 10 µl reaction, with FA buffer (Table. 5.16). Reactions were incubated on ice for 45
min. Afterward, the reactions were supplemented with 2 µl of NG buffer (Table. 5.16) and loaded
on a pre-equilibrated 6% polyacrylamide gel (60min in 1X TG buffer at 100V at 4°C).
Table 5.17. 6% native acrylamide gels
Component Volume
TG buffer 10X 7.5 ml
30% Acrylamide 15 ml
TEMED 75 µl
APS 750 µl
Glycerol (5%) 4.31 ml
ddH2O to 75 µl
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Electrophoresis was performed at 4°C in 1X TG buffer and ran at 220V for 3-4h. The gel was
analyzed and imaged at 488nm using the Amersham Typhoon gel imager (GE Healthcare).
5.2.4 Crystallization and data collection
Initial crystallization attempts of hStau1 and mutants were performed at 4°C and 20 °C in 96-well
MRC sitting drop plates with different crystallisations screens ( crystallisations screens are listed in
Table. 5.7). The crystallization setups were based on 200nl droplets (100nl protein or complex plus
100nl reservoir) over 70nl reservoir solution. The drops were dispensed using a mosquito® crystal
dispensing robot (TTP Labtech Ltd, UK) with 8 channels.
Initial hits were usually optimized in 96 well plates using the dragonfly® crystal screen optimizer
(TTP Labtech Ltd, UK). The plates were automatically imaged using the imaging system of the
crystallization facility in house.
hStau1dsRBD3-4 - ARF1 SBS complex
Crystals of hStau1dsRBD3-4 in complex with ARF1 SBS were obtained at 22°C by mixing 1 µl of
complex solution at 7 mg/ml with 1 µl of reservoir solution (50 mM MgCl2, 120 mM KCl, 50 mM
sodium cacodylate, pH 6.33, 5% 1,6-hexanediol) using the sitting drop vapor diffusion. The crystals
were cryo-protected with mother liquor supplemented with 30% 1,6-Hexanediol and flash frozen in
liquid nitrogen.
ARF1 SBS
Crystals of ARF1 SBS were obtained at 22°C using the sitting drop vapor diffusion (1.7 M
(NH4)2SO4 and 100 mM Tri-sodium citrate, pH 6.2). The crystal was cryo-protected by transfer
into mother liquor supplemented with 20% glycerol and then flash frozen in liquid nitrogen.
The diffraction data were collected at the PXIII (hStau1dsRBD3-4 - ARF1 SBS complex native and
derivative) and PXII (ARF1 SBS unbound) beamlines of the Swiss Light Source.
Data processing and structure determination
The diffraction data were indexed, integrated, and scaled with the XDS program (Kabsch, 2010).
For the hStau1dsRBD3-4 - ARF1 SBS complex, the determined space group P41212 correspond
to the tetragonal crystal system with cell dimension a = b = 105.9 Å, c = 169.2 Å, a = b = g = 90°.
In the case of the ARF1 SBS the space group was H32 with cell dimensions of a = b = 43.8 Å,
c = 452.1 Å, a = b = 90°, g = 120°. The structure of the hStau1182–360 (dsRBD3-4 construct) -
ARF1 SBS complex and the apo ARF1 SBS was solved by MR using PHASER (McCoy et al.,
2007). The phases of the complex were obtained with an optimized dsRBD search model by the
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superposition of DmStau dsRBD5 PDB ID: 5CFF Jia et al. (2015) and human hStau1 dsRBD5
PDB ID: 4DKK. For the ARF1 SBS the phases were determined with a 19 bp A-form RNA as a
search model (PDB: 1QC0 Klosterman P.S. (1999)). The asymmetric unit was assumed to contain
one complex in the ASU for the complex and one and a half molecules for the ARF1 SBS. Both
models were built manually using COOT and subjected to iterative cycles of restrained refinement
with PHENIX. Interactions within the structure were analyzed with the program PISA.
In attempting to verify the model and find anomalous scatterers, a single-wavelength anomalous
diffraction (SAD) data were collected from the hStau1dsRBD3-4 - ARF1 SBS complex with SeMet-
substituted hStau1dsRBD3-4. The calculated anomalous-difference Fourier map (using log-likelihood
gradient maps in PHASER) allowed unambiguous determination of the positions of the antiparallels
dsRBD3A and dsRBD3B as well as dsRBD4.
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MPI Max Planck Institute
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mRNA messenger RNA
mRNP mRNA ribonucleoprotein particle
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MW Molecular Weight
NF90 Nuclear factors 90
NLS nuclear localization signal
NMD Nonsense-Mediated mRNA Decay
NMR nuclear magnetic resonance
Nova 2 Neuro-oncological ventral antigen 2
NS1 nonstructural protein 1
nt nucleotide
osk oskar mRNA
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PDB Protein Data Bank
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PKR dsRNA-dependent protein kinase
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Pol II RNA polymerase II
pros prospero mRNA
PTGR post-transcriptional gene regulation
Pur-alpha purine-rich element binding protein A
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Abbreviation
RBD RNA binding domain
RER rough endoplasmatic reticulum
RGCs radial glial cells
RI refractive index
RISC RNA-induced silencing complex
RIPs RNA coimmunoprecipitations
RMSD Root Mean Square Deviation
RNA Ribonucleic acid
RRM RNA-Recognition Motif
rRNAs ribosomal RNAs
SAD single-wavelength anomalous diffraction
SBS Staufen Binding Site
SD standard deviations
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis
SEC size exclusion chromatography
SEC-MALLS SEC coupled with Multi-Angle Laser Light Scattering
SeMet seleno-methionine
SLS Swiss Light Source
SMD Staufen Mediated Decay
SRS Staufen recognized structures
ssDNA single-stranded DNA
SSM Staufen-swapping motif
ssRNA single-stranded RNA
Stau Staufen
TBD Tubulin binding domain
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Abbreviation
TEV Tobacco Etch Virus
TLS Transport and Localization Sequence
TRBP human TAR-binding protein
UTR untranslated region
vRNA viral RNA
XDS X-ray Detector Software
Xl Xenopus laevis
Xlrbpa Xenopus laevis RNA-binding protein A
zf zinc finger
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